UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 579.

A

Abola, EE; Bairoch, A; Barker, WC; Beck, S; Benson, DA; Berman, H; Cameron, G; ... CODATA Task Grp Biological Macromo, ; + view all (2000) Quality control in databanks for molecular biology. BIOESSAYS , 22 (11) 1024 - 1034.

Adeyemo, D; Imtiaz, F; Toffa, S; Lowdell, M; Winslet, M; (2000) Bax/Bcl-2 ratio is elevated by combines 5FU and antioxidant in colon cancer cells in vitro. GUT , 46 A54 - A54.

Adeyemo, D; Toffa, S; Lowdell, M; Winslet, M; (2000) 5 ASA upregulates 5FU induced Bax expression in colon cancer cells in vitro. BRIT J CANCER , 83 58 - 58.

Adeyemo, D; Toffa, S; Lowdell, M; Winslet, M; (2000) Antioxidants augment 5FU upregulation of Bax expression in colon cancer cells in vitro. BRIT J CANCER , 83 58 - 58.

Ahmed, F; Watts, MJ; Ings, SJ; Flynn, M; Linch, DC; (2000) Poor viability of freshly apheresed PBSC harvests: Implications for overnight storage before cryopreservation or additional manipulative procedures. BLOOD , 96 (11) 380A - 380A.

Al Saffar, N; Burrows, MG; Revell, PA; (2000) Immunopathological reaction to orthopaedic biomaterial. In: Cracium, C and Ardelean, , (eds.) Current Problems in Cellular and Molecular Biology. (pp. 37-50). RISOPRINT: Cluj-Napoca.

Al Saffar, N; Revell, PA; (2000) Differential expression of transforming growth factor-alpha and macrophage colony-stimulating factor/colony-stimulating factor-1R (c-fms) by multinucleated giant cells involved in pathological bone resorption at the site of orthopaedic implants. Journal of Orthopaedic Research , 18 (5) pp. 800-807.

Al Saffar, N; Revell, PA; (2000) Heavy infiltrate of B-lymphocytic nodules/aggregates in the bone-implant interface in relation to orthopaedic protheses: Report of two cases. The Journal of Pathology , 192 (Suppl) 28A-28A.

Al Saffar, N; Revell, PA; (2000) Frustrated wound healing: the immunopathogenesis of bone resorption. In: Davies, JE, (ed.) Bone Engineering. (pp. 152-160). em squared incorporated: Toronto.

Aleong, IC; Bates, AW; Baithun, SI; (2000) Secondary neoplasms of the kidney: a clinico-pathological review of 443 cases. J PATHOL , 190 42A - 42A.

Alison, MR; Poulsom, R; Jeffery, R; Dhillon, AP; Quaglia, A; Jacob, J; Novelli, M; ... Wright, NA; + view all (2000) Cell differentiation - Hepatocytes from nonhepatic adult stem cells. NATURE , 406 (6793) 257 - 257.

Alison, MR; Poulsom, R; Jeffery, R; Dhillon, AP; Quaglia, A; Jacob, J; Novelli, M; ... Wright, NA; + view all (2000) Hepatocytes from non-hepatic adult stem cells. Nature , 406 (6793) 257-. 10.1038/35018642.

Alison, MR; Poulsom, R; Jeffrey, R; Dhillon, AP; Quaglia, A; Jacob, J; Novelli, M; ... Wright, NA; + view all (2000) Plasticity of human haemopoietic stem cells: Differentiation to hepatocytes after liver and bone marrow transplantation. J PATHOL , 192 2A - 2A.

Allcock, C; Allen, N; Anaf, G; Apler, A; Austin, MP; Bennett, C; Birleson, P; ... others, ; + view all (2000) Sections. Australasian Psychiatry , 8 (4) p. 409.

Allen, AJR; Gale, RE; Harrison, CN; Machin, SJ; Linch, DC; (2000) Lack of pathogenic mutations in the 5 ' UTR of the thrombopoietin gene in patients with non-familial essential thrombocythaemia. BLOOD , 96 (11) 742A - 742A.

Allford, SL; Harrison, P; Lawrie, AS; Cohen, H; Mackie, IJ; Machin, SJ; (2000) Recurrent thrombotic thrombocytopenic purpura: Association of durable remission with cyclosporin and recovery in vWF-cleaving protease activity. Presented at: UNSPECIFIED.

Allford, SL; Harrison, P; Lawrie, AS; Liesner, R; Mackie, IJ; Machin, SJ; (2000) von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura. British Journal of Haematology , 111 (4) pp. 1215-1222. 10.1046/j.1365-2141.2000.02503.x.

Allford, SL; Harrison, P; Lawrie, AS; Liesner, R; Mackie, IJ; Machin, SJ; (2000) von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura. BRIT J HAEMATOL , 111 (4) 1215 - 1222.

Almeida, A; Mehta, A; (2000) Malaria and Anaemia. Postgraduate Doctor (Caribbean) , 16 (9) pp. 392-394.

Anagnostopoulos, I; Hansmann, ML; Franssila, K; Harris, M; Harris, NL; Jaffe, ES; Han, J; ... Stein, H; + view all (2000) European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. BLOOD , 96 (5) pp. 1889-1899.

Ancliff, PJ; Gale, RE; Liesner, R; Hann, IM; Linch, DC; (2000) Mutations in ELA2 encoding for neutrophil elastase are a frequent finding in sporadic but not familial severe congenital neutropenia. BLOOD , 96 (11) 445A - 445A.

Anderson, FM; O'Hare, CC; Hartley, JA; Robins, DJ; (2000) Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agents. ANTI-CANCER DRUG DES , 15 (2) 119 - 126.

Anderson, L; Porter, JB; Wonke, B; Walker, JM; Holden, S; Davis, BA; Prescott, E; ... Pennell, DJ; + view all (2000) Cardiac iron deposition is not predicted by conventional markers of iron overload in homozygous beta-thalassaemia. BLOOD , 96 (11) 606A - +.

Anderson, L; Porter, JB; Wonke, B; Walker, JM; Holden, S; Davis, BA; Prescott, E; ... Pennell, DJ; + view all (2000) Relationship of myocardial iron overload to right and left ventricular function in homozygous beta-thalassemia. BLOOD , 96 (11) 605A - +.

Anderson, LJ; Holden, S; Davis, BA; Prescott, E; Charrier, C; Bunce, NH; Firmin, DN; ... Pennell, DJ; + view all (2000) A novel method of cardiac iron measurement using magnetic resonance T2*imaging in thalassemia: Validation and clinical application. CIRCULATION , 102 (18) 403 - 403.

Anderson, R; Macdonald, I; Corbett, T; Whiteway, A; Prentice, HG; (2000) A method for the preparation of highly purified adeno-associated virus using affinity column chromatography, protease digestion and solvent extraction. Journal of Virological Methods , 85 (1-2) pp. 23-34.

Anthony, A; Pounder, RE; Dhillon, AP; Wakefield, AJ; Inflammatory Bowel Disease Study G, ; (2000) Similarities between ileal Crohn's disease and indomethacin experimental jejunal ulcers in the rat. ALIMENT PHARM THER , 14 (2) 241 - 245.

Anthony, A; Sim, R; Dhillon, AP; Pounder, RE; Wakefield, AJ; (2000) Granulomatous vasculitis in Crohn's disease: Associated with the extra-mural vasculature. GASTROENTEROLOGY , 118 (4) A340 - A340.

Anthony, A; Sim, R; Guillaume, JL; Strosberg, AD; Dhillon, AP; Pounder, RE; Wakefield, AJ; (2000) Beta(beta)(3)-adrenergic receptors in human pancreatic islet and duodenal somatostatin neuroendocrine cells. ALIMENT PHARM THERAP , 14 (5) 579 - 585.

Ardeshna, KM; Corney, CP; Ings, SJ; Watts, MJ; Linch, DC; Devereux, S; (2000) A clinically applicable method for the ex vivo generation of antigen-presenting cells from CD34(+) progenitors. VOX SANG , 79 (1) 46 - 52.

Ardeshna, KM; Pizzey, AR; Devereaux, S; Khwaja, A; (2000) The PI3 kinase, p38 SAP kinase, and NF-kappa B signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. BLOOD , 96 (3) 1039 - 1046.

Ardeshna, KM; Pizzey, AR; Thomas, NSB; Orr, S; Linch, DC; Devereux, S; (2000) Monocyte-derived dendritic cells do not proliferate and are not susceptible to retroviral transduction. BRIT J HAEMATOL , 108 (4) 817 - 824.

Ardeshna, KM; Walker, SJ; Devereux, S; Linch, DC; Khwaja, A; (2000) The p38 stress activated protein kinase mediates the increased responsiveness of mature dendritic cells to macrophage inhibitory protein 3 beta (MIP3 beta) and secondary lymphoid chemokine (SLC). BLOOD , 96 (11) 33A - 33A.

Ardeshna, KM; Walker, SJ; Devereux, S; Linch, DC; Khwaja, A; (2000) The p38 stress activated protein kinase mediates the increased responsiveness of mature dendritic cells to macrophage inhibitory protein 3β (mip3β) and secondary lymphoid chemokine (slc). Blood , 96 (11 PART )

Arguello, JR; Madrigal, JA; (2000) DNA conformational analysis. In: Bidwell, J and Navarette, C, (eds.) Histocompatibility Testing. (pp. 247-266). Imperial College Press: UK.

Ariad, S; Benharroch, D; Lupu, L; Davidovici, B; Dupin, N; Boshoff, C; (2000) Early peripheral lymph node involvement of human herpesvirus 8-associated, body cavity-based lymphoma in a human immunodeficiency virus-negative patient. ARCH PATHOL LAB MED , 124 (5) 753 - 755.

Arkenau, HT; Hegglin, I; Luthi, U; Gebbers, JO; (2000) Trichosporosis. Schweizerische Medizinische Wochenschrift , 130 (49) 1914-.

Arkenau, HT; Hegglin, I; Lüthi, U; (2000) [Trichosporosis]. Schweiz Med Wochenschr , 130 (49) 1914-.

Arkenau, HT; Luthi, U; (2000) Amyloidomas. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT , 130 (35) p. 1244.

Arkenau, HT; Luthi, U; (2000) Soap-bubble lesions. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT , 130 (51-52) p. 2017. Gold open access

Arkenau, HT; Luthi, U; Gebbers, JO; (2000) Amyloidomas. Schweizerische Medizinische Wochenschrift , 130 (35) 1244-.

Arnold, J; Cohen, H; (2000) Heparin-induced skin necrosis. British journal of haematology , 111 992-.

Arostegui, JI; Gallardo, D; Rodriguez-Luaces, M; Querol, S; Madrigal, JA; Garcia-Lopez, J; Granena, A; (2000) Genomic typing of minor histocompatibility antigen HA-1 by reference strand mediated conformation analysis (RSCA). Tissue Antigens , 56 pp. 69-76.

Arris, CE; Boyle, FT; Calvert, AH; Curtin, NJ; Endicott, JA; Garman, EF; Gibson, AE; ... Yu, W; + view all (2000) Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. J MED CHEM , 43 (15) 2797 - 2804.

Ashford, P; Gozzard, D; Jones, J; Revill, J; Wallis, J; Bruce, M; Chapman, J; ... British Committee for Standards in Haematology Blood Transfusion, F; + view all (2000) Guidelines for blood bank computing. Transfusion medicine , 10 pp. 307-314.

Aubert, G; Dodi, A; Koh, M; Grace, S; Potter, M; Prentice, G; Travers, P; (2000) Monitoring of cytomegalovirus antigen specific T cells in post bone marrow transplant patients. Human Immunology , 61 (Suppl)

Azzabi, AS; Calvert, AH; Verrill, M; Kelly, C; Lind, MJ; Newell, DR; Griffin, MJ; ... Boddy, AV; + view all (2000) Phase I and pharmacokinetic study of temozolomide and paclitaxel in the treatment of malignant melanoma. Clinical Cancer Research , 6 539-.

B

Baddeley, H; Brodrik, PM; Taylor, NJ; Abdelatti, MO; Jordan, LC; Vasudevan, AS; Phillips, H; ... Hoskin, PJ; + view all (2000) Gas exchange parameters in radiotherapy patients during breathing of 2%, 3.5% and 5% carbogen gas mixtures. British Journal of Radiology , 73 (874) pp. 1100-1104.

Baker, RJ; Hart, SM; Mehta, AB; Wickremasinghe, RG; Prentice, HG; Hoffbrand, AV; Ross, DD; (2000) Expression of breast cancer resistance protein (BCRP) in malignant cells from patients with B-chronic lymphocytic leukaemia (B-CLL) and acute lymphoblastic leukemia (ALL). BLOOD , 96 (11) 824A - 824A.

Barlow, HC; Bowman, KJ; Curtin, NJ; Calvert, AH; Golding, BT; Huang, B; Loughlin, PJ; ... Griffin, RJ; + view all (2000) Resistance-modifying agents. Part 7: 2, 6-disubstituted-4,8-dibenzylaminopyrimido[5,4-d]pyrimidines that inhibit nucleoside transport in the presence of alpha(1)-acid glycoprotein (AGP). BIOORG MED CHEM LETT , 10 (6) 585 - 589.

Bates, AW; (2000) Birth defects described in Elizabethan ballads. J ROY SOC MED , 93 (4) 202 - 207.

Bates, AW; Baithun, SI; (2000) Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases. HISTOPATHOLOGY , 36 (1) 32 - 40.

Bates, AW; Feakins, RM; Scheimberg, I; (2000) Congenital gastrointestinal stromal tumour is morphologically indistinguishable from the adult form, but does not express CD117 and carries a favourable prognosis. HISTOPATHOLOGY , 37 (4) 316 - 322.

Bates, AW; Norton, AJ; Baithun, SI; (2000) Malignant lymphoma of the urinary bladder: a clinicopathological study of 11 cases. J CLIN PATHOL , 53 (6) 458 - 461.

Baugh, M; Gavrilovic, J; Davies, JR; Williams, T; Hughes, DA; Sampson, MJ; (2000) Monocyte matrix metalloproteinase production in Type 2 diabetes and controls. In: (pp. A274-A274). SPRINGER-VERLAG

Baynes, KCR; Beeton, CA; Panayotou, G; Stein, R; Soos, M; Hansen, T; Simpson, H; ... Whitehead, JP; + view all (2000) Natural variants of human p85 alpha phosphoinositide 3-kinase in severe insulin resistance: a novel variant with impaired insulin-stimulated lipid kinase activity. DIABETOLOGIA , 43 (3) pp. 321-331. 10.1007/s001250050050.

Beck, S; Trowsdale, J; (2000) The human major histocompatibility complex: Lessons from the DNA sequence. ANNU REV GENOM HUM G , 1 117 - 137.

Bench, AJ; Nacheva, EP; Hood, TL; Holden, JL; French, L; Swanton, S; Champion, KM; ... Green, AR; + view all (2000) Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG). Oncogene , 19 (34) pp. 3902-3913. 10.1038/sj.onc.1203728.

Bench, AJ; Nacheva, EP; Hood, TL; Holden, JL; French, L; Swanton, S; Champion, KM; ... UK Canc Cytogenetics Grp, ; + view all (2000) Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. ONCOGENE , 19 (34) 3902 - 3913.

Bentley, J; Arris, CE; Boyle, FT; Calvert, AH; Curtin, NJ; Endicott, JA; Gibson, AE; ... Newell, DR; + view all (2000) Structure-activity relationships and cellular effects of novel purine- and pyrimidine-based cyclin dependent kinase inhibitors. Clinical Cancer Research , 6 328-.

Bentzen, SM; Hoskin, P; Roos, D; Nielsen, OS; (2000) Fractionated radiotherapy for metastatic bone pain: Evidence- based medicine or ...? International Journal of Radiation Oncology Biology Physics , 46 (3) pp. 681-682.

Bentzen, SM; Saunders, MI; Dische, S; Parmar, MK; (2000) Updated data for chart in NSCLC: Further analyses. RADIOTHERAPY AND ONCOLOGY , 55 (1) pp. 86-87. 10.1016/S0167-8140(00)00160-2.

Berardi, R; Strauss, S; Blake, D; Whelan, JS; (2000) Is it safe to substitute oral for intravenous mesna? A case control study. In:

Berger, LA; Warwick, R; Mehta, A; (2000) Isolated candida infection of the pterygoid muscles in a patient with Gauchers disease. American Journal of Rentgenology , 176 1332-.

Beverley, PCL; Maini, MK; (2000) Differences in the regulation of CD4 and CD8 T-cell clones during immune responses. In: PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. (pp. 401 - 406). ROYAL SOC LONDON

Bhatia, J; Sharma, SK; Chester, KA; Pedley, RB; Boden, RW; Read, DA; Boxer, GM; ... Begent, RH; + view all (2000) Catalytic activity of an in vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion protein. Int J Cancer , 85 (4) pp. 571-577.

Bhatia, J; Sharma, SK; Chester, KA; Pedley, RB; Boden, RW; Read, DA; Boxer, GM; ... Begent, RHJ; + view all (2000) Catalytic activity of an in vivo tumor targeted anti-CEA scFv :: carboxypeptidase G2 fusion protein. INT J CANCER , 85 (4) 571 - 577.

Bhatia, J; Sharma, SK; Chester, KA; Pedley, RB; Boden, RW; Read, DA; Boxer, GM; ... Begent, RHJ; + view all (2000) Catalytic activity of an in vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion protein. International Journal of Cancer , 85 (4) pp. 571-577. 10.1002/(SICI)1097-0215(20000215)85:4<571::AID-IJC20>3.0.CO;2-1.

Bhatia, J; Sharma, SK; Pedley, BR; Boxer, G; Robson, L; Begent, RHJ; Chester, K; (2000) In vitro & in vivo stability of purified MFE 23 :: CPG2 fusion protein from Pichia pastoris. In: (pp. p. 71). CHURCHILL LIVINGSTONE

Bhatia, J; Sharma, SK; Pedley, BR; Boxer, G; Robson, L; Begent, RHJ; Chester, K; (2000) In vitro and in vivo stability of purified MFE 23 :: CPG2 fusion protein from Pichia pastoris. In: (pp. p. 170).

Boddy, AV; Griffin, MJ; Wright, JG; Sludden, JA; Thomas, HD; Fishwick, K; Plummer, R; ... Calvert, AH; + view all (2000) Paclitaxel and carboplatin dose-intensity and duration of infusion in the treatment of ovarian cancer. British Journal of Cancer , 83 203-.

Bodmer, JG; Bodmer, WF; Marsh, SGE; (2000) HLA Nomenclature: The Name of the Rose. In: Lecher, R and Warrens, A, (eds.) HLA and Disease. (pp. 147-161). Academic Press: London.

Boehm, MK; Corper, AL; Wan, T; Sohi, MK; Sutton, BJ; Thornton, JD; Keep, PA; ... Perkins, SJ; + view all (2000) Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts. Biochem J , 346 Pt pp. 519-528.

Boehm, MK; Corper, AL; Wan, T; Sohi, MK; Sutton, BJ; Thornton, JD; Keep, PA; ... Perkins, SJ; + view all (2000) Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts. BIOCHEM J , 346 519 - 528.

Bogunia-Kubik, K; Perez-Cruz, I; Fallen, PR; Madrigal, JA; Cohen, SBA; (2000) Cord blood lymphocytes have a low frequency of cytokine producing T cells due to a high threshold for activation. IMMUNOL LETT , 72 (3) pp. 145-146.

Borthwick, NJ; Lowdell, M; Salmon, M; Akbar, AN; (2000) Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type IIFN, and increases susceptibility to activation-induced apoptosis. INT IMMUNOL , 12 (7) 1005 - 1013.

Boshoff, C; (2000) Kaposi's sarcoma herpesvirus: from cell biology to pathogenesis. AIDS , 14 S5 - S5.

Botchway, ANS; Flores, NA; Sheridan, DJ; Cohen, H; (2000) Storage pool defect in pooled huffy coat platelet concentrates within the shelf-life period. CLIN LAB HAEMATOL , 22 (1) 21 - 27.

Brady, CS; Bartholomew, JS; Burt, DJ; Duggan-Keen, MF; Glenville, S; Telford, N; Little, AM; ... Stern, PL; + view all (2000) Multiple mechanisms underlie HLA dysregulation in cervical cancer. Tissue Antigens , 55 (5) pp. 401-411.

Broadstock, M; Michie, S; Gray, J; Mackay, J; Marteau, TM; (2000) The psychological consequences of offering mutation searching in the family for those at risk of hereditary breast and ovarian cancer - A pilot study. PSYCHO-ONCOL , 9 (6) 537 - 548.

Brooks, N; McHugh, PJ; Lee, M; Hartley, JA; (2000) Alteration in the choice of DNA repair pathway with increasing sequence selective DNA alkylation in the minor groove. CHEM BIOL , 7 (9) 659 - 668.

Burcombe, RJ; Makris, A; Richman, PI; Daley, F; Noble, S; Wilson, GD; (2000) Persistence of c-erbB-2 overexpression after neoadjuvant chemotherapy for primary breast cancer. British Journal of Cancer , 83 36-.

Burcombe, RJ; Ostler, PJ; Ayoub, AW; Hoskin, PJ; (2000) The role of staging CT scans in the treatment of prostate cancer: A retrospective audit. Clinical Oncology , 12 (1) pp. 32-35.

Burk, K; (2000) Troublemaker: The Life and History of A.J.P. Taylor. [Book]. Yale University Press: London & New Haven.

Burk, K; (2000) War and Anglo-American Financial Relations in the Twentieth Century. In: Levanthal, F and Quinault, R, (eds.) Anglo-American Attitudes: From Revolution to Partnership. (pp. 243-260). Ashgate Press: Aldershot.

C

COULONVAL, K; VANDEPUT, F; STEIN, RC; KOZMA, SC; LAMY, F; DUMONT, JE; (2000) Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin. Biochemical Journal , 348 (2) pp. 351-358. 10.1042/bj3480351.

Calabrese, CR; Curtin, NJ; Canan-Koch, SS; Batey, MA; Thomas, HD; Kyle, S; Wang, LZ; ... Newell, DR; + view all (2000) Design and evaluation of novel potent inhibitors of poly(ADP-ribose) polymerase. Clinical Cancer Research , 6 150-.

Calabrese, CR; Curtin, NJ; Canan-Koch, SS; Batey, MA; Thomas, HD; Kyle, S; Wang, LZ; ... Newell, DR; + view all (2000) Design and evaluation of novel potent inhibitors of poly(ADP-ribose) polymerase. CLIN CANCER RES , 6 4496S - 4496S.

Calder, JDF; Buttery, L; Revell, P; Polak, JM; Pearse, M; (2000) Apoptosis - The underlying mechanism of cellular death in osteonecrosis of the femoral head? The Journal of Pathology , 190 (SS) A21-.

Calder, JDF; Buttery, L; Revell, P; Polak, JM; Pearse, M; (2000) Increased eNOS and iNOS expression in osteonecrosis of the femoral head. The Journal of Pathology , 190 (SS) A22-.

Calder, JDF; Pearse, M; Revell, P; (2000) Extension of osteonecrosis into the proximal femur of patients with osteonecrosis of the femoral head. The Journal of Pathology , 190 (SS) A22-.

Calvert, H; Sessa, C; Carmichael, J; Calvert, P; Zucchetti, M; Marsoni, S; Van den Bosch, S; ... Camboni, G; + view all (2000) An intermittent phase I and pharmacokinetic study of BBR3464, a novel cationic triplatinum complex. ANN ONCOL , 11 132 - 132.

Calvert, P; Jayson, G; Atkinson, R; Ganesan, T; Cervantes-Ruiperez, A; Vasey, P; Adams, M; ... Cheverton, P; + view all (2000) Phase II clinical and pharmacokinetic study of exatecan mesylate (DX-8951f) in patients with advanced ovarian cancer, refractory to, or relapsed after platinum and taxane. Annals of Oncology , 11 372P-.

Calvert, PM; O'Neill, V; Azzabi, A; Hughes, A; Plummer, R; Twelves, C; Robinson, A; ... Calvert, AH; + view all (2000) A phase I clinical and pharmacokinetic study of EPO906 (epothilone B) in patients with advanced solid tumours. Clinical Cancer Research , 6 575-.

Calvert, PM; O'Neill, V; Azzabi, A; Hughes, A; Plummer, R; Twelves, C; Robinson, A; ... Calvert, AH; + view all (2000) A phase I clinical and pharmacokinetic study of EPO906 (epothilone B) in patients with advanced solid tumours. CLIN CANCER RES , 6 4581S - 4581S.

Caplin, ME; Hilson, AJ; Hochhauser, D; Burroughs, AK; Tibbals, J; Watkinson, AF; Dhillon, AP; (2000) High dose Indium-III Octreotide therapy for disseminated carcinoid tumour. Gastroenterology , 118 (4 Supp) AGA-.

Caplin, ME; Hilson, AJ; Hochhauser, D; Burroughs, AK; Tibbals, J; Watkinson, AF; Dhillon, AP; (2000) High dose indium-111 octreotide therapy for disseminated carcinoid tumour. GUT , 46 A74 - A74.

Caplin, ME; Hilson, AJ; Hochhauser, D; Burroughs, AK; Tibbals, J; Watkinson, AF; Dhillon, AP; (2000) High dose indium-III octreotide therapy for disseminated carcinoid tumor. Gastroenterology , 118 (4) 2751-.

Caplin, ME; Hilson, AJ; Hochhauser, D; Burroughs, AK; Tibbals, J; Watkinson, AF; Dhillon, AP; (2000) High dose indium-III octreotide therapy for disseminated carcinoid tumor. GASTROENTEROLOGY , 118 (4) A516 - A516.

Carmichael, J; Conron, M; Beynon, H; Crow, J; Warner, TT; (2000) Churg-Strauss syndrome presenting with visual loss. RHEUMATOLOGY , 39 (12) 1433 - 1434.

Casey, JL; Pedley, RB; King, DJ; Boden, R; Chapman, A; Yarranton, GTAB; R, HJ; (2000) Improved tumour targetting of divalent Fab’ fragments modified with polyethylene glycol. Tumor Targeting , 4 pp. 235-244.

Cerone, MA; Marchetti, A; Bossi, G; Blandino, G; Sacchi, A; Soddu, S; (2000) p53 is involved in the differentiation but not in the differentiation-associated apoptosis of myoblasts. Cell Death Differ , 7 (5) pp. 506-508. 10.1038/sj.cdd.4400676.

Chakrabarti, S; Kottaridis, P; Ogormon, P; Peggs, K; Osman, H; Chopra, R; Mackinnon, S; (2000) High incidence of early and late CMV infection and delayed immune reconstitution after allogeneic transplants with nonmyeloablative conditioning using Campath (anti-CD52 antibody). In: BLOOD. (pp. 586A - +). AMER SOC HEMATOLOGY

Chakraverty, R; McMillan,, AK; Chopra, R; Goldstone, AH; (2000) High dose therapy for the treatment of non-Hodgkin's lymphoma. In: Armitage, JO and Antman, KH, (eds.) High Dose Cancer Therapy. Williams and Wilkins

Chakraverty, R; Robinson, S; Peggs, K; Kottaridis, P; Watts, M; Ings, S; Hale, G; ... Mackinnon, S; + view all (2000) Excessive T-cell depletion adversely affects transplant-related mortality following allogeneic stem cell transplantation. In: BLOOD. (pp. 587A - +). AMER SOC HEMATOLOGY

Chang, J; Powles, TJ; Allred, DC; Ashley, SE; Makris, A; Gregory, RK; Osborne, CK; (2000) Prediction of clinical outcome from primary tamosifen by expression of biologic markers in breast cancer patients. Clinical Cancer Research , 6 (2) pp. 616-621.

Chatterjee, R; Andrews, HO; McGarrigle, HH; Kottaridis, PD; Lees, WR; Mackinnon, S; Ralph, DJ; (2000) Cavernosal arterial insufficiency is a major component of erectile dysfunction in some recipients of high-dose chemotherapy/chemoradiotherapy for haematological malignancies. BONE MARROW TRANSPL , 25 (11) 1185 - 1189.

Chatterjee, R; Gemidjioglu, ME; Davis, BA; Helal, MA; Cullum, I; Porter, JB; (2000) Longitudinal evaluation of the contribution of hypogonadism to the severity of osteoporosis in homozygous beta-thalassemia. BLOOD , 96 (11) 23B - 23B.

Chatterjee, R; Kottaridis, PD; Lees, WR; Ralph, DJ; Goldstone, AH; (2000) Cavernosal arterial insufficiency and erectile dysfunction in recipients of high-dose chemotherapy and total body irradiation for multiple myeloma. LANCET LTD

Chatterjee, R; Kottaridis, PD; McGarrigle, HH; Mackinnon, S; Goldstone, AH; (2000) Patterns of Leydig cell insufficiency in adults following bone marrow transplantation for hematological malignancies. BLOOD , 96 (11) 403A - 403A.

Chester, KA; Bhatia, J; Boxer, G; Cooke, SP; Flynn, AA; Huhalov, A; Mayer, A; ... Begent, RHJ; + view all (2000) Clinical applications of phage-derived sFvs and sFv fusion proteins. DISEASE MARKERS , 16 (1-2) 53 - 62.

Chester, KA; Mayer, A; Bhatia, J; Robson, L; Spencer, DI; Cooke, SP; Flynn, AA; ... Begent, RH; + view all (2000) Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer. Cancer Chemother Pharmacol , 46 Sup S8-12.

Chester, KA; Mayer, A; Bhatia, J; Robson, L; Spencer, DIR; Cooke, SP; Flynn, AA; ... Begent, RHJ; + view all (2000) Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer. In: CANCER CHEMOTHERAPY AND PHARMACOLOGY. (pp. S8 - S12). SPRINGER-VERLAG

Chilcott, IT; Margara, R; Cohen, H; Rai, R; Skull, J; Pickering, W; Regan, L; (2000) Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization. FERTIL STERIL , 73 (3) 526 - 530.

Chopra, R; Eaton, JD; Grassi, A; Potter, M; Shaw, B; Salat, C; Neumeister, P; ... Barbui, T; + view all (2000) Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. Br J Haematol , 111 (4) pp. 1122-1129.

Cirinna, M; Trotta, R; Salomoni, P; Kossev, P; Wasik, M; Perrotti, D; Calabretta, B; (2000) Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation. BLOOD , 96 (12) 3915 - 3921.

Clark, R; Byatt, SA; Bennett, CF; Brama, M; Martineau, M; Moorman, AV; Roberts, K; ... Harrison, CJ; + view all (2000) Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia. LEUKEMIA , 14 (2) pp. 241-246. 10.1038/sj.leu.2401654.

Clingen, PH; Denholm, EE; De Silva, IU; Hockey, A; Hartley, JA; (2000) Response of human DNA repair defective cell lines to DNA interstrand agents. British Journal of Cancer , 83 138-.

Clingen, PH; Denholm, EE; De Silva, IU; Hockey, A; Hartley, JA; CRC Drug DNA Interaction Res Grp, ; (2000) Response of human DNA repair defective cell lines to DNA interstrand agents. BRIT J CANCER , 83 63 - 63.

Codish, S; Abu-Shakra, M; Ariad, S; Zirkin, HJ; Yermiyahu, T; Dupin, N; Boshoff, C; (2000) Manifestations of three HHV-8-related diseases in an HIV-negative patient: Immunoblastic variant multicentric Castleman's disease, primary effusion lymphoma, and Kaposi's sarcoma. AM J HEMATOL , 65 (4) 310 - 314.

Codrington, R; O'Connor, HE; Jalali, GR; Carrara, P; Papaioannou, M; Hart, SM; Hoffbrand, AV; ... Foroni, L; + view all (2000) Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value. BRITISH JOURNAL OF HAEMATOLOGY , 111 (4) pp. 1071-1079. 10.1046/j.1365-2141.2000.02464.x.

Cohen, H; Love, E; Williamson, L; Jones, H; (2000) Serious hazards of transfusion: a scheme for haemovigilance. Presented at: 28th world congress of the international society of haematology, Toronto.

Cohen, SB; Woolley, J; Bogunia-Kubik, K; Natarajan, P; Kotecha, R; Belaramani, L; Fallen, PR; ... Madrigal, JA; + view all (2000) Macrophage colony stimulating factor (M-CSF) within cord blood sera may be partially responsible for the reduced proliferation of cord blood T cells. European Cytokine Network , 11 (4) pp. 608-617.

Cohen, SBA; Gluckman, E; Rubinstein, P; Madrigal, JA; (2000) Cord Blood Characteristics: Role in Stem Cell Transplantation. Martin Dunitz: London.

Cohen, SBA; Morgan, CL; Perez-Cruz, I; Perandin, F; Martinez, B; Madrigal, JA; (2000) Cord blood serum does not increase lymphocyte responses in comparison to adult serum. HUM IMMUNOL , 61 pp. 111-114.

Cooke, SP; Boxer, GM; Spencer, DIR; Lawrence, L; Pedley, RB; Chester, KA; Begent, RHJ; (2000) Tumour vascular targeting using a novel anti-vascular endothelial cell growth factor (VEGF) scFv antibody. British Journal of Cancer , 83 14-.

Cooke, SP; Boxer, GM; Spencer, DIR; Lawrence, L; Pedley, RB; Chester, KA; Begent, RHJ; (2000) Tumour vascular targeting using a novel anti-vascular endothelial cell growth factor (VEGF) scFv antibody. British Journal of Cancer , 83 (Suppl) 14-.

Cooke, SP; Boxer, GM; Spencer, DIR; Lawrence, L; Pedley, RB; Chester, KA; Begent, RHJ; (2000) Tumour vascular targeting using a novel anti-vascular endothelial cell growth factor (VEGF) scFv antibody. BRIT J CANCER , 83 11 - 11.

Cooooke, SP; Boxer, GM; Spencer, DIR; Lawrence, L; Pedley, RB; Chester, KA; Begent, RHJ; (2000) Tumour vascular targeting using a novel anti-vascular endothelial cell growth factor (VEGF) scFv antibody. In: (Proceedings) British Journal of Cancer. (pp. p. 14).

Corell, A; Pay, AL; Little, AM; Hoddinott, MA; Arguello, JR; Borton, M; Dunne, C; ... Marsh, SGE; + view all (2000) Reference strand mediated conformation analysis resolves HLB-DRB1 typing ambiguities when matching for unrelated bone marrow transplantation. TISSUE ANTIGENS , 56 (1) pp. 82-86. 10.1034/j.1399-0039.2000.560111.x.

Coulonval, K; Vandeput, F; Stein, RC; Kozma, SC; Lamy, F; Dumont, JE; (2000) Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin. Biochem J , 348 Pt pp. 351-358.

Cox, ST; Hossain, E; McWhinnie, A; Prokupek, B; Madrigal, JA; Little, AM; (2000) HLA-B*8202 identified in a Caucasoid potential bone marrow donor. Tissue Antigens , 56 (2) pp. 188-191.

Cox, ST; Hossain, E; McWhinnie, A; Prokupek, B; Madrigal, JA; Little, AM; (2000) HLA-B*8202 identified in a Caucasoid potential bone marrow donor. Tissue Antigens , 56 (2) pp. 188-191.

Cox, ST; Little, AM; Madrigal, JA; Marsh, SGE; (2000) Sequence of HLA-A*0209 confirmed. IMMUNOGENETICS , 51 (6) pp. 489-490. 10.1007/s002510050648.

Cox, ST; McWhinnie, A; Prokupek, B; Madrigal, JA; Little, AM; (2000) HLA-B*4413 identified in a UK Caucasoid potential bone marrow donor. Tissue Antigens , 55 (2) pp. 185-187.

Cox, ST; McWhinnie, A; Prokupek, B; Madrigal, JA; Little, AM; (2000) HLA-B*4413 identified in a UK Caucasoid potential bone marrow donor. Tissue Antigens , 55 (2) pp. 185-187.

Cross, TG; Scheel-Toellner, D; Henriquez, NV; Deacon, E; Salmon, M; Lord, JM; (2000) Serine/threonine protein kinases and apoptosis. Exp Cell Res , 256 (1) pp. 34-41. 10.1006/excr.2000.4836.

Crow, JC; Rolfe, KJ; Levine, TS; Reid, W; MacLean, AB; Perrett, CW; (2000) Lichen sclerosus, squamous hyperplasia and differentiated VIN - a pathway to vulval malignancy. J PATHOL , 192 22A - 22A.

Cunningham, D; Mainwaring, PN; Gregory, W; Hoskin, P; Hancock, B; Smith, P; Hudson, GV; (2000) Mitoxantrone is superior to doxorubicin in a multi-agent weekly regimen for patients with high-grade lymphoma over the age of 60 years: Results of a BNLI randomised trial of PACEBO vs. British Journal of Cancer , 83 (Su 1-.

Curtin, NJ; Calvert, AH; Canan-Koch, S; Durkacz, BW; Griffin, RJ; Golding, BT; Hostomsky, Z; ... Yu, XH; + view all (2000) Chemopotentiation studies with two classes of potent (polyADP-ribose) polymerase (PARP) inhibitors in human lung and colon carcinoma cell lines. Clinical Cancer Research , 6 205-.

Curtin, NJ; Calvert, AH; Canan-Koch, S; Durkacz, BW; Griffin, RJ; Golding, BT; Hostomsky, Z; ... Yu, XH; + view all (2000) Chemopotentiation studies with two classes of potent (polyADP-ribose) polymerase (PARP) inhibitors in human lung and colon carcinoma cell lines. CLIN CANCER RES , 6 4507S - 4507S.

D

Dattani, MT; Martinez-Barbera, JP; Thomas, PQ; Brickman, JM; Gupta, R; Wales, JKH; Hindmarsh, PC; ... Robinson, ICAF; + view all (2000) Molecular genetics of septo-optic dysplasia. HORMONE RESEARCH , 53 26 - 33.

Davis, BA; O'Sullivan, C; Eliahoo, J; Jarritt, P; Porter, JB; (2000) Long-term prognostic value of serial measurement of ventricular function in the management of homozygous beta-thalassemia. BLOOD , 96 (11) 23B - 23B.

Davis, BA; Porter, JB; (2000) Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia. BLOOD , 95 (4) 1229 - 1236.

De Silva, IU; McHugh, PJ; Clingen, PH; Hartley, JA; (2000) Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. MOL CELL BIOL , 20 (21) 7980 - 7990.

Dearling, JLJ; Flynn, AA; Pagoulatos, C; Wilson, GD; Woodcock, M; Denholm, E; Hartley, J; ... Pedley, RB; + view all (2000) Influence of tumour cell response and nuclide selection on the efficacy of RIT. British Journal of Cancer , 83 (Suppl) 173-.

Dearling, JLJ; Flynn, AA; Pagoulatos, C; Wilson, GD; Woodcock, M; Denholm, E; Hartley, J; ... Pedley, RB; + view all (2000) Influence of tumour cell response and nuclide selection on the efficacy of RIT. In: BRIT J CANCER. (pp. 72 - 72). CHURCHILL LIVINGSTONE

Dearling, JLJ; Flynn, AA; Watson, RJ; Boxer, GM; Sutcliffe-Goulden, J; Boden, R; Begent, RHJ; (2000) : Potential for use of [C-14]2DG as a predictor of [F-18]FDG tumour distribution for assessment of therapeutic efficacy. In: (pp. pp. 394-395).

Delaney, CA; Wang, LZ; Kyle, S; White, AW; Calvert, AH; Curtin, NJ; Durkacz, BW; ... Newell, DR; + view all (2000) Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines. CLIN CANCER RES , 6 (7) 2860 - 2867.

Demetris, A; Adams, D; Bellamy, C; Blakolmer, K; Clouston, A; Dhillon, AP; Fung, J; ... Yamabe, H; + view all (2000) Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology , 31 (3) pp. 792-799. 10.1002/hep.510310337.

Demuth, I; Wlodarski, M; Tipping, AJ; Morgan, NV; de Winter, JP; Thiel, M; Grasl, S; ... Digweed, M; + view all (2000) Spectrum of mutations in the Fanconi anaemia group G gene, FANCG/XRCC9. EUR J HUM GENET , 8 (11) 861 - 868.

Dey, A; McCloskey, EV; Taube, T; Cox, R; Panda, KC; Ashford, RU; Forster, M; ... Kanis, JA; + view all (2000) Metacarpal morphometry using a semi-automated technique in the assessment of osteoporosis and vertebral fracture risk. OSTEOPOROSIS INTERNATIONAL , 11 (11) pp. 953-958. 10.1007/s001980070034.

Dhanjal, S; Verma, L; Macdonald, F; Roberts, E; Davison, V; Hulten, M; (2000) Simple and rapid prenatal DNA diagnosis of common chromosome abnormalities. BRIT J OBSTET GYNAEC , 107 (6) 820 - 820.

Di Francesco, AM; Hargreaves, RHJ; Wallace, TW; Mayalarp, SP; Hazrati, A; Hartley, JA; Butler, J; (2000) Anti-tumour properties of novel diaziridinylquinones. British Journal of Cancer , 83 152-.

Di Francesco, AM; Hargreaves, RHJ; Wallace, TW; Mayalarp, SP; Hazrati, A; Hartley, JA; Butler, J; (2000) Anti-tumour properties of novel diaziridinylquinones. Clinical Cancer Research , 6 309-.

Di Francesco, AM; Hargreaves, RHJ; Wallace, TW; Mayalarp, SP; Hazrati, A; Hartley, JA; Butler, J; (2000) Anti-tumour properties of novel diaziridinylquinones. British Journal of Cancer , 83 152-.

Di Francesco, AM; Hargreaves, RHJ; Wallace, TW; Mayalarp, SP; Hazrati, A; Hartley, JA; Butler, J; (2000) Anti-tumour properties of novel diaziridinylquinones. Clinical Cancer Research , 6 309-.

Di Francesco, AM; Hargreaves, RHJ; Wallace, TW; Mayalarp, SP; Hazrati, A; Hartley, JA; Butler, J; (2000) Anti-tumour properties of novel diaziridinylquinones. BRIT J CANCER , 83 66 - 66.

Di Francesco, AM; Hargreaves, RHJ; Wallace, TW; Mayalarp, SP; Hazrati, A; Hartley, JA; Butler, J; (2000) Anti-tumour properties of novel diaziridinylquinones. CLIN CANCER RES , 6 4527S - 4527S.

Di Francesco, AM; Hargreaves, RHJ; Wallace, TW; Mayalarp, SP; Hazratis, A; Hartley, JA; Butler, J; (2000) The abnormal cytotoxicities of 2,5-diaziridinyl-1,4-benzoquinone-3-phenyl esters. ANTI-CANCER DRUG DES , 15 (5) 347 - 359.

Diaz, RM; Bateman, A; Emiliusen, L; Fielding, A; Trono, D; Russell, SJ; Vile, RG; (2000) A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy. GENE THERAPY , 7 (19) pp. 1656-1663. 10.1038/sj.gt.3301277.

Ding, GR; Yaguchi, H; Yoshida, M; Miyakoshi, J; (2000) Increase in X-ray-induced mutations by exposure to magnetic field (60 Hz, 5 mT) in NF-kappaB-inhibited cells. Biochem Biophys Res Commun , 276 (1) pp. 238-243. 10.1006/bbrc.2000.3455.

Dodi, IA; Morgan, CL; Madrigal, JA; (2000) The significance of HLA matching in cord blood stem cell transplantation. In: Cohen, SBA and Gluckman, E and Rubinstein, P and Madrigal, JA, (eds.) Cord Blood Transplantation. (pp. 205-238). Martin Dunitz Ltd: London.

Dodi, IA; Morgan, CL; Madrigal, JA; (2000) The significance of HLA matching in cord blood stem cell transplantation. In: Cohen, SBA and Gluckman, E and Rubinstein, P and Madrigal, JA, (eds.) Cord Blood Transplantation. (pp. 205-238). Martin Dunitz Ltd: London.

Donohoe, S; Kingdom, JCP; Mackie, IJ; Burrell, S; Quenby, S; Jauniaux, E; Machin, SJ; (2000) Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies. THROMB HAEMOSTASIS , 84 (1) 32 - 38.

Donohoe, S; Kingdom, JCP; Mackie, IJ; Burrell, S; Quenby, S; Jauniaux, E; Machin, SJ; (2000) Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies. Thrombosis and Haemostasis , 84 (1) pp. 32-38.

Duchesne, GM; Bolger, JJ; Griffiths, GO; Roberts, JT; Graham, JD; Hoskin, PJ; Fossa, SD; ... Parmar, MKB; + view all (2000) A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: Results of Medical Research Council Trial BA09. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , 47 (2) pp. 379-388. 10.1016/S0360-3016(00)00430-2.

Duke, V; Kapoor, A; Gricks, C; Melo, J; Foroni, L; (2000) BCL10 deletions in haematological malignancies: a cloning artefact? BRITISH JOURNAL OF HAEMATOLOGY , 111 (4) pp. 1106-1108. 10.1046/j.1365-2141.2000.02447.x.

Dunlop, DJ; Connery, L; O, BM; Thatcher, N; Lee, SM; Hill, S; Thatcher, N; (2000) Phase II study of carboplatin and vinorelbine in small cell lung cancer. In: (Proceedings) 2000 ASCO Annual Meeting/36th Annual Meeting, New Orleans, LA.. (pp. 518a-). Proceedings of the American Society of Clinical Oncology

Dunlop, DJ; O'Brien, ME; Lee, SM; Hill, S; Thatcher, N; (2000) Multicentre phase II study of carboplatin (AUC 5) and vinorelbine in small cell lung cancer (SCLC). In: (pp. p. 42). CHURCHILL LIVINGSTONE

Dupin, N; Diss, TL; Kellam, P; Tulliez, M; Du, MQ; Sicard, D; Weiss, RA; ... Boshoff, C; + view all (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. BLOOD , 95 (4) 1406 - 1412.

Dutt, N; Bates, AW; Baithun, SI; (2000) Secondary neoplasms of the male genital tract with different patterns of involvement in adults and children. HISTOPATHOLOGY , 37 (4) 323 - 331.

E

Eccles, DM; Evans, DG; Mackay, J; (2000) Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG). Journal of Medical Genetics , 37 (3) pp. 203-209.

Ehlers, A; Beck, S; Forbes, SA; Trowsdale, J; Volz, A; Younger, R; Ziegler, A; (2000) MHC-linked olfactory receptor loci exhibit polymorphism and contribute to extended HLA/OR-haplotypes. GENOME RES , 10 (12) 1968 - 1978.

Eisen, T; Boshoff, C; Mak, I; Sapunar, F; Vaughan, MM; Pyle, L; Johnston, SRD; ... Gore, ME; + view all (2000) Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer. BRIT J CANCER , 82 (4) 812 - 817.

El Hamidi, A; Kocjan, G; Du, MQ; (2000) Cervical smear: A PCR-based clonality analysis. J PATHOL , 192 25A - 25A.

Ellis, PE; Fong, LFWT; Rolfe, KJ; Crow, JC; MacLean, AB; Perrett, CW; (2000) Vascular Endothelial Growth Factor (VEGF) and disease progression in Paget's disease of the vulva and the breast. J PATHOL , 192 23A - 23A.

Eren, E; Travers, PJ; (2000) The molecular structure of the major histocompatibility complex and its molecular interactions. In: Lechler, R and Warrens, A, (eds.) HLA in Health and Disease. Academic Press

Ezoe, S; Matsumura, I; Tanaka, H; Kawasaki, A; Machii, T; Enver, T; Kanakura, K; (2000) GATA-1 inhibits cytokine-dependent growth of hematopoietic cells through the inhibition of STAT3 and AP-1 activities. BLOOD , 96 (11) 680A-680A.

Ezoe, S; Matsumura, I; Tanaka, H; Kawasaki, A; Machii, T; Enver, T; Kanakura, Y; (2000) GATA-2 down-regulates c-myc and affects cytokine-dependent growth of hematopoietic cells. BLOOD , 96 (11) 285A-285A.

F

Falini, B; Fizzotti, M; Pucciarini, A; Bigerna, B; Marafioti, T; Gambacorta, M; Pacini, R; ... Stein, H; + view all (2000) A monoclonal antibody (MUM1p) detects expression of the MUM 1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. BLOOD , 95 (6) pp. 2084-2092.

Farquharson, MJ; Bagshaw, AP; Porter, JB; Abeysinghe, RD; (2000) The use of skin Fe levels as a surrogate marker for organ Fe levels, to monitor treatment in cases of iron overload. PHYS MED BIOL , 45 (5) 1387 - 1396.

Fielding, AK; Chapel-Fernandes, S; Chadwick, MP; Bullough, FJ; Cosset, FL; Russell, SJ; (2000) A hyperfusogenic gibbon ape leukemia envelope glycoprotein: Targeting of a cytotoxic gene by ligand display. HUMAN GENE THERAPY , 11 (6) pp. 817-826. 10.1089/10430340050015437.

Fischer, G; Arguello, JR; Perez-Rodriguez, M; McWhinnie, A; Marsh, SGE; Travers, PJ; Madrigal, JA; (2000) Sequence-specific oligonucleotide probing for MICB alleles reveals associations with MICA and HLA-B. IMMUNOGENETICS , 51 (7) pp. 591-599. 10.1007/s002510000179.

Fischer, G; Perez-Rodriguez, M; Arguello, JR; Cox, ST; McWhinnie, A; Travers, PJ; Madrigal, JA; (2000) Three novel MICB alleles. Tissue Antigens , 55 (2) pp. 166-170.

Flanagan, AM; Sarma, U; Steward, CG; Vellodi, A; Horton, MA; (2000) Study of the nonresorptive phenotype of osteoclast-like cells from patients with malignant osteopetrosis: A new approach to investigating pathogenesis. J BONE MINER RES , 15 (2) 352 - 360.

Flores, NA; Botchway, ANS; Turner, MA; Cohen, H; Sheridan, DJ; (2000) Products of the platelet release reaction accentuate the ischaemia-induced reduction in action potential duration (APD(95)) in the isolated perfused guinea-pig heart. In: J PHYSIOL-LONDON. (pp. 111P - 112P). CAMBRIDGE UNIV PRESS

Flores, NA; Botchway, ANS; Turner, MA; Cohen, H; Sheridan, DJ; (2000) Products of the platelet release reaction influence cardiac electrophysiology independently of platelet-platelet interactions. PLATELETS , 11 (7) 415 - 417.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Dearling, J; Watson, R; Boden, B; (2000) A model based approach for the optimisation of radioimmunotherapy through antibody design and radionuclide selection. Cancer Biotherapy and Radiopharmaceuticals , 15 (4 2000)

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Dearling, J; Watson, R; Boden, B; (2000) Multiparameter analysis using 3D reconstructions of digital images showing the spatial and temporal distribution of factors influencing radioimmunotherapy. Cancer Biotherapy and Radiopharmaceuticals , 15 (4 2000)

Foss, HD; Marafioti, T; Stein, H; (2000) Hodgkin's lymphoma: classification and pathogenesis. PATHOLOGE , 21 (2) pp. 113-123. 10.1007/s002920050379.

Foss, HD; Marafioti, T; Stein, H; (2000) The many faces of anaplastic large cell lymphoma. PATHOLOGE , 21 (2) pp. 124-136. 10.1007/s002920050380.

Francis, RJ; Sharma, SK; Sena, L; Springer, C; Green, AJ; Hope-Stone, LD; Martin, J; ... Begent, RHJ; + view all (2000) A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. British Journal of Cancer , 83 (Suppl) 18-.

Francis, RJ; Sharma, SK; Sena, L; Springer, C; Green, AJ; Hope-Stone, LD; Martin, J; ... Begent, RHJ; + view all (2000) A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. British Journal of Cancer , 83 43-.

Francis, RJ; Sharma, SK; Sena, L; Springer, C; Green, AJ; Hope-Stone, LD; Martin, J; ... Begent, RHJ; + view all (2000) A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. BRIT J CANCER , 83 18 - 18.

Freeman, A; Morris, LS; Odell, E; Kocjan, G; Patterson, A; Marker, A; Laskey, RA; (2000) Improved detection of dysplastic and malignant cells in cytological preparations using antibodies against minichromosome maintenance proteins. J PATHOL , 190 45A - 45A.

Friedman, HS; Kerby, T; Calvert, H; (2000) Temozolomide and treatment of malignant glioma. CLIN CANCER RES , 6 (7) 2585 - 2597.

G

Gardiner, C; Mackie, IJ; Machin, SJ; (2000) Evaluation of a new automated latex particle immunoassay for D-dimer: IL test D-dimer. Laboratory Hematology , 6 (3) pp. 147-150.

Gardiner, C; Mackie, IJ; Malia, RG; Jones, DW; Winter, M; Leeming, D; Taberner, DA; ... Greaves, M; + view all (2000) The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant. BRIT J HAEMATOL , 111 (4) 1230 - 1235.

Gascoigne, NRJ; Alam, SM; Lin, CM; McGuire, MV; Marine, S; Niederberger, N; Redpath, S; ... Zal, T; + view all (2000) T cell receptor binding kinetics and special role of V alpha in T cell development and activation. Immunologic Research , 21 (2-3) pp. 225-231.

Gibson, V; Anderson, RJ; Hartley, JA; McAdam, SR; Cairns, D; (2000) Anthraquinone-oligodeoxynucleotide conjugates as inhibitors of gene transcription. J PHARM PHARMACOL , 52 (6) 599 - 602.

Gorodetsky, R; Lotan, C; Piggot, K; Pierce, L; Polyansky, I; Dische, S; Saunders, MI; ... Vexler, A; + view all (2000) Late effects of dose fractionation on the mechanical properties of breast skin following post-lumpectomy radiotherapy (vol 45, pg 893, 1999). International Journal of Radiation Oncology Biology Physics , 47 (2) p. 545.

Grant, JW; Scott, IS; Stoeber, K; Happerfield, LC; Anderson, JR; Williams, GH; (2000) Comparison of expression of minichromosome maintenance protein 2 and MIB-1 in primary CNS tumours. In: (Proceedings) 181st Meeting of the Pathological Society of Great Britain and Ireland. (pp. A9-A9). Wiley: Hoboken, NJ.

Greaves, M; Cohen, H; Machin, SJ; Mackie, I; (2000) Guidelines on the investigation and management of the antiphospholipid syndrome. BRIT J HAEMATOL , 109 (4) 704 - 715.

Greene, JN; Linch, DC; Miller, CB; (2000) Current treatments for infection in neutropenic patients with hematologic malignancy. Oncology (Williston Park) , 14 (8 Suppl ) pp. 31-34.

Gribble, S; Andrews, K; Williams, D; Tillett, A; Bloxham, D; Proffit, J; Hackbarth, M; ... Nacheva, E; + view all (2000) Fluorescence in situ hybridization detection of two telomeres on the short arm of a derived chromosome 16 in an infant with thrombocytopenia. Cancer Genet Cytogenet , 120 (2) pp. 99-104.

Gribble, S; Bench, A; Huntly, B; Green, AR; Nacheva, EP; (2000) Molecular cytogenetics of polycythemia vera; Lack of occult rearrangements detectable by FISH mapping, CGH, and colour karyotyping. BLOOD , 96 (11) 742A - 742A.

Gribble, S; Philips, M; Andrews, K; Roberts, I; Morrison, L; Grace, CD; Green, AR; (2000) Chromosome segment 8q23-qter identified as a common region of overrepresentation in CML blast crisis; A study of 10 CML derived cell lines using CGH, colour karyotyping, chromosome band specific painting and FISH mapping. BLOOD , 96 (11) 740A - 740A.

Gribble, SM; Roberts, I; Grace, C; Andrews, KM; Green, AR; Nacheva, EP; (2000) Cytogenetics of the chronic myeloid leukemia-derived cell line K562: Karyotype clarification by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and locus-specific fluorescence in situ hybridization. In: CANCER GENET CYTOGEN. (pp. 1 - 8). ELSEVIER SCIENCE INC

Griffin, RJ; Arris, CE; Bleasdale, C; Boyle, FT; Calvert, AH; Curtin, NJ; Dalby, C; ... Golding, BT; + view all (2000) Resistance-modifying agents. 8. Inhibition of O-6-alkylguanine-DNA alkyltransferase by O-6-alkenyl-, O-6-cycloalkenyl-, and O-6-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O-6-(1-cyclopentenylmethyl)guanine. J MED CHEM , 43 (22) 4071 - 4083. 10.1021/jm000961o.

Griffin, RJ; Arris, CE; Calvert, AH; Curtin, NJ; Jewsbury, P; Endicott, JA; Gibson, AE; ... Lawrie, A; + view all (2000) Design, synthesis, and biological evaluation of O-6-alkylguanine and O-4-alkylpyrimidine cyclin-dependent kinase inhibitors. Abstracts of Papers of the American Chemical Society , 219 296-MEDI.

Griffin, RJ; Arris, CE; Calvert, AH; Curtin, NJ; Jewsbury, P; Endicott, JA; Gibson, AE; ... Lawrie, A; + view all (2000) Design, synthesis, and biological evaluation of O-6-alkylguanine and O-4-alkylpyrimidine cyclin-dependent kinase inhibitors. ABSTR PAP AM CHEM S , 219 U55 - U55.

Groot De, NG; Otting, N; Watkins, DI; Doxiadis, GM; Arguello, R; Madrigal, JA; Bontrop, RE; (2000) MHC class I diversity in a West-African chimpanzee population: implications for HIV research. Immunogenetics , 51 pp. 398-409.

Gudi, M; Hasserjian, R; Gomez, K; Abboudi, Z; Kaczmarski, R; Szydlo, R; Lampert, I; (2000) Prognostic factors in high grade non-hodgkin's lymphomas in the elderly. Blood , 96 (11 PART )

Guo, A; Salomoni, P; Luo, JY; Shih, A; Zhong, S; Gu, W; Pandolfi, PP; (2000) The function of PML in p53-dependent apoptosis. NAT CELL BIOL , 2 (10) 730 - 736.

Guo, AL; Salomoni, P; Luo, JY; Shih, A; Zhong, S; Gu, W; Pandolfi, PP; (2000) Role of PML in p53-dependent apoptosis. BLOOD , 96 (11) 822A - 822A.

H

Habib, N; (2000) Cancer Gene Therapy Past Achievements and Future Challenges. Springer

Hackshaw, AK; Law, MR; Wald, NJ; (2000) Passive smoking and lung cancer: increased risk is not disputed. British Medical Journal , 321 pp. 1221-1222.

Hackshaw, AK; Wald, NJ; (2000) Revised distribution parameters for serum markers for trisomy 18. J MED SCREEN , 7 (4) 215 - 215.

Hackshaw, AK; Wald, NJ; Michell, MJ; Field, S; Wilson, ARM; (2000) An investigation into why two-view mammography is better than one-view in breast cancer screening. CLIN RADIOL , 55 (6) 454 - 458.

Hampel, C; Tolner, B; Webley, SD; Lam, E; Hartley, JA; Hochhauser, D; (2000) Role of E2F-1 in chemosensitivity to minor groove binding agents. British Journal of Cancer , 83 (Suppl) 65-.

Hampel, C; Tolner, B; Webley, SD; Lam, E; Hartley, JA; Hochhauser, D; (2000) Role of E2F-1 in chemosensitivity to minor groove binding agents. BRIT J CANCER , 83 23 - 23.

Hansen, SH; Zegers, MMP; Woodrow, M; Rodriguez-Viciana, P; Chardin, P; Mostov, KE; McMahon, M; (2000) Induced expression of Rnd3 is associated with transformation of polarized epithelial cells by the Raf-MEK-extracellular signal-regulated kinase pathway. MOL CELL BIOL , 20 (24) 9364 - 9375.

Hargreaves, RHJ; Hartley, JA; Butler, J; (2000) Mechanisms of action of quinone-containing alkylating agents: DNA alkylation by aziridinylquinones. FRONT BIOSCI , 5 E172 - E180.

Harland, PC; Harland, SJ; (2000) John Charles Harland - Obituaries. BMJ (Clinical Research Ed.) , 320 (7242) p. 1149.

Harland, SJ; (2000) Conundrum of the hereditary component of testicular cancer. LANCET , 356 (9240) 1455 - 1456.

Hart, SM; Ganeshaguru, K; Mehta, A; (2000) Multi-drug resistance in haematological malignancies. CME Bulletin Haematology , 3 (1) pp. 6-8.

Hartley, JA; Brooles, PJ; Mc Hugh, PJ; Clingen, PH; Gregson, SJ; Howard, PW; and Thurston, DE; (2000) SJG-136 (NSC-D694501)-A novel DNA sequence specific minor groove crosslinking agent with significant antitumor activity. PROC AM ASSOC CANCER RES , 41 2703-.

Hartley, JA; Hazrati, A; Hodgkinson, TJ; Kelland, LR; Khanim, R; Shipman, M; Suzenet, F; (2000) Synthesis, cytotoxicity and DNA cross-linking activity of symmetrical dimers based upon the epoxide domain of the azinomycins. CHEM COMMUN (23) 2325 - 2326.

Hartley, JA; Hazrati, A; Kelland, LR; Khanim, R; Shipman, M; Suzenet, F; Walker, LF; (2000) A Synthetic Azinomycin Analogue with Demonstrated DNA Cross-Linking Activity: Insights into the Mechanism of Action of this Class of Antitumor Agent The authors gratefully acknowledge the financial support provided by the CRC and the EPSRC. We are indebted to the EPSRC National Mass Spectrometry Centre for performing mass spectral measurements, and the EPSRC Chemical Database Service at Daresbury.1. Angew Chem Int Ed Engl , 39 (19) pp. 3467-3470.

Hartley, JA; Hazrati, A; Kelland, LR; Khanim, R; Shipman, M; Suzenet, F; Walker, LF; (2000) A synthetic azinomycin analogue with demonstrated DNA cross-linking activity: Insights into the mechanism of action of this class of antitumor agent. ANGEW CHEM INT EDIT , 39 (19) 3467 - +.

Harvey, CJ; Peniket, AJ; Miszkiel, K; Patterson, K; Goldstone, AH; Mackinnon, S; Hall-Craggs, MA; (2000) MR angiographic diagnosis of cerebral venous sinus thrombosis following allogeneic bone marrow transplantation. BONE MARROW TRANSPLANTATION , 25 (7) pp. 791-795. 10.1038/sj.bmt.1702238.

Helmberg, W; Hegland, J; Hurley, CK; Maiers, M; Marsh, SGE; Muller, C; Rozemuller, EH; (2000) Going back to the roots: effective utilisation of HLA typing information for bone marrow registries requires full knowledge of the DNA sequences of the oligonucleotide reagents used in the testing. TISSUE ANTIGENS , 56 (1) pp. 99-102. 10.1034/j.1399-0039.2000.560115.x.

Heyworth, CM; May, GE; Dexter, M; Gale, KB; Enver, T; (2000) Lineage programming and re-programming by transcription factor GATA-1. BLOOD , 96 (11) 454A-454A.

Hing, KA; Gibson, IR; Revell, PA; Best, SM; Bonfield, W; (2000) Influence of phase purity on the in vivo response to hydroxyapatite. Bioceramics , 192-1 pp. 373-376.

Hochhauser, D; (2000) Relevance of mitochondrial DNA in cancer. LANCET , 356 (9225) 181 - 182.

Hoddinott, MA; Cox, ST; McWhinnie, AJ; Marsh, SGE; Ogilvie, H; Madrigal, JA; Little, AM; (2000) A new allele, HLA-B*1555, identified in an African patient awaiting bone marrow transplantation. TISSUE ANTIGENS , 55 (5) pp. 463-466. 10.1034/j.1399-0039.2000.550512.x.

Hooshmand-Rad, R; Hajkova, L; Klint, P; Karlsson, R; Vanhaesebroeck, B; Claesson-Welsh, L; Heldin, CH; (2000) The PI 3-kinase isoforms p110 alpha and p110 beta have differential roles in PDGF- and insulin-mediated signaling. JOURNAL OF CELL SCIENCE , 113 (2) pp. 207-214.

Horwich, A; Oliver, RTD; Wilkinson, PM; Mead, GM; Harland, SJ; Cullen, MH; Roberts, JT; ... MRC Testicular Tumour Working Par, ; + view all (2000) A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. BRIT J CANCER , 83 (12) 1623 - 1629. 10.1054/bjoc.2000.1498.

Hoskin, PJ; (2000) Palliative radiotherapy for disseminated disease. In: Greco, C and Zelefsky, MJ, (eds.) Radiotherapy of prostate cancer. (pp. 463-477). Harwood Academic Publishers: Amsterdam.

Hoskin, PJ; (2000) Bone metastases - radiotherapy. In: Rubens, RD and Mundy, GR and Martin, D, (eds.) Cancer and the skeleton. (pp. 159-170). : London.

Hoskin, PJ; Phillips, H; Jackson, S; Wims, P; Verma, N; Saunders, MI; (2000) Carbogen and nicotinamide with radical radiotherapy for bladder cancer: Updated Phase II results and launch of the BCON Phase III randomised trial. British Journal of Cancer , 83 84-.

Hoskin, PJ; Stratford, MRL; Folkes, LK; Regan, J; Yarnold, JR; (2000) Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity. The Lancet , 355 (9213) pp. 1428-1429.

Hoskin, PJ; Vidler, K; (2000) Vaginal vault brachytherapy: the effect of varying bladder volumes on normal tissue dosimetry. British Journal of Radiology , 73 (872) pp. 864-866.

Hughes, AN; Griffin, MJ; Newell, DR; Calvert, AH; Johnston, A; Kerr, B; Lee, C; ... Boddy, AV; + view all (2000) Clinical pharmacokinetic and in vitro combination studies of nolatrexed dihydrochloride (AG337, Thymitaq (TM)) and paclitaxel. BRIT J CANCER , 82 (9) 1519 - 1527.

J

Jackson, A; Carrara, P; Duke, V; Sinclair, P; Papaioannou, M; Harrison, CJ; Foroni, L; (2000) Deletion of 6q16-q21 in human lymphoid malignancies: a mapping and deletion analysis. Cancer Research , 60 (11) pp. 2775-2779.

Jackson, TR; Brown, FD; Nie, ZZ; Miura, K; Foroni, L; Sun, JL; Hsu, VW; ... Randazzo, PA; + view all (2000) ACAPs are Arf6 GTPase-activating proteins that function in the cell periphery. JOURNAL OF CELL BIOLOGY , 151 (3) pp. 627-638. 10.1083/jcb.151.3.627.

Jacob, JP; Milne, S; Beck, S; Kaufman, J; (2000) The major and a minor class II beta-chain (B-LB) gene flank the Tapasin gene in the B-F/B-L region of the chicken major histocompatibility complex. IMMUNOGENETICS , 51 (2) 138 - 147.

Jamieson, NF; Novelli, M; Thorpe, SM; Mosse, A; Bown, SG; Lovat, LB; (2000) Photodynamic therapy using ALA for high grade dysplasia in Barrett's oesophagus. In: (pp. 722-).

Jankowska, PJ; Babb, P; Quinn, M; Whelan, JS; (2000) A population based study of the incidence and mortality for osteosarcoma in England and Wales. In:

Joiner, M; Short, S; Mayes, C; Lambin, P; Marples, B; Shah, N; Saunders, MI; (2000) Low dose hypersensitivity and induced radioresistance: Possibilities for therapy and implications for radioprotection. International Journal of Radiation Oncology Biology Physics , 46 (3) p. 692.

Jones, DT; Wickremasinghe, RG; Mehta, AB; Prentice, HG; Ganeshaguru, K; (2000) Enchancement of the TNF-related apoptis-inducing ligand (TRAIL) mediated apoptosis of AML cells by cytotoxic agents. BLOOD , 96 (Abstr) 79a-.

Jones, DT; Wickremasinghe, RG; Mehta, AB; Prentice, HG; Ganeshaguru, K; (2000) Enhancment of TNF-related apoptosis-inducing ligand (TRAIL) mediated apoptosis of AML cells by cytotoxic agents. BLOOD , 96 (11) 79A - 79A.

Jones, DT; Wickremasinghe, RG; Mehta, AB; Prentice, HG; Hoffbrand, AV; Ganeshaguru, K; (2000) Activation of caspase 8 in the absence of FAS ligation in the killing of B-CLL cells by cytotoxic drugs and radiation. British Journal of Haematology , 108 (Abstr) 72-.

Jones, DW; Gallimore, MJ; Mackie, IJ; Harris, SL; Winter, M; (2000) Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII. BRIT J HAEMATOL , 110 (3) 721 - 726.

Jones, DW; Mackie, IJ; Gallimore, MJ; Winter, M; (2000) Are antibodies to coagulation factor XII a risk factor for recurrent fetal loss? BLOOD , 96 (11) 269A - 269A.

K

Kelly, PF; Vandergriff, J; Nathwani, A; Nienhuis, AW; Vanin, EF; (2000) Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. BLOOD , 96 (4) 1206 - 1214.

Kenneally, A; Liang, B; Barber, LD; (2000) The peptide-binding motif of HLA-B*3505. Immunogenetics , 51 (10) pp. 866-868.

Keshtgar, M; Kocjan, G; Saunders, C; Davidson, T; Baum, M; Ell, PJ; Taylor, I; (2000) Imprint cytology and the sentinel node in breast carcinoma. In: (pp. 680-).

Keshtgar, MRS; Kocjan, G; Davidson, T; Ralphs, D; Taylor, I; Ell, PJ; (2000) Touch imprint cytology and the sentinel node in breast carcinoma. In: (Proceedings) Sentinel Node 2000.

Khakoo, SI; Ling, R; Scott, I; Dodi, AI; Harrison, TJ; Dusheiko, GM; Madrigal, JA; (2000) Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals. Gut , 47 (1) pp. 137-143.

Kinashi, T; Katagiri, K; Watanabe, S; Vanhaesebroeck, B; Downward, J; Takatsu, K; (2000) Distinct mechanisms of alpha(5)beta(1) integrin activation by Ha-Ras and R-Ras. JOURNAL OF BIOLOGICAL CHEMISTRY , 275 (29) pp. 22590-22596. 10.1074/jbc.M000633200. Gold open access

Kitchener, H; Ledermann, J; Miles, A; (2000) Key Advances in the Management of Ovarian Cancer. [Book]. UK Key Advances in Clinical Practice Series. Aesculapius Medical Press: London.

Koh, MBC; Prentice, HG; Corbo, M; Cotter, FE; Morgan, M; Ravell, P; Lowdell, MW; (2000) Alloantigen-specific T cell depletion: From the bench to the bedside via a murine model. Hematology and Cell Therapy , 42 (2-3) pp. 187-190.

Kottaridis, PD; Gale, RE; Frew, ME; Harrison, G; Langabeer, SE; Belton, AA; Walker, H; ... Linch, DC; + view all (2000) The presence of a FLT3 mutation in AML adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the MRC AML 10 and 12 trials. BLOOD , 96 (11) 825A - 825A.

Kottaridis, PD; Milligan, DW; Chopra, R; Chakraverty, RK; Chakrabarti, S; Robinson, S; Peggs, K; ... Mackinnon, S; + view all (2000) In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. BLOOD , 96 (7) 2419 - 2425.

Kottaridis, PD; Milligan, DW; Mahendra, P; Chopra, R; Chakraverty, R; Chakrabarti, S; Peggs, K; ... UK Collaborative Study, ; + view all (2000) Non-myeloablative conditioning limits transplant related mortality in patients who have previously failed high dose treatment. In: BLOOD. (pp. 553A - +). AMER SOC HEMATOLOGY

Kottaridis, PD; Peggs, K; Devereux, S; Goldstone, AH; Mackinnon, S; (2000) Simultaneous occurrence of Clostridium difficile and Cytomegalovirus colitis in a recipient of autologous stem cell transplantation. HAEMATOLOGICA , 85 (10) 1116 - 1117. Gold open access

Kottaridis, PD; Peggs, K; Lawrence, A; Verfuerth, S; Chatterjee, R; Telfer, P; Porter, JB; ... Goldstone, AH; + view all (2000) One antigen mismatched related donor bone marrow transplant in a patient with acute lymphoblastic leukaemia and beta-thalassaemia major: potential cure of both marrow disorders. BONE MARROW TRANSPL , 25 (6) 677 - 678.

L

Lalancette, M; Michallet, M; Szydlo, R; Rezvani, K; Mackinnon, S; Blaise, D; Finke, J; ... Apperley, J; + view all (2000) The importance of patient selection in non-myeloablative stem cell transplant (NMSCT) for acute and chronic leukemia, myelodysplastic syndrome, and myeloma. BLOOD , 96 (11) 199A - 199A.

Lalancette, M; Rezvani, K; Szydlo, R; Mackinnon, S; Juliusson, G; Michallet, M; Slavin, S; ... Apperley, J; + view all (2000) Excellent outcome of non-myeloablative stem cell transplant (NMSCT) for good risk myeloma: The EBMT experience. BLOOD , 96 (11) 204A - 204A.

Langabeer, SE; Gale, RE; Rollinson, SJ; Morgan, GJ; Linch, DC; (2000) Mutations in the AML1 gene in acute myeloid leukaemia patients with FAB types M0 and M7. BLOOD , 96 (11) 698A - 698A.

Langabeer, SE; Gale, RE; Walker, H; Linch, DC; (2000) Reported cryptic rearrangements of CBF beta-MYH11 in acute myeloid leukaemia are not due to false priming of contaminating DNA. LEUKEMIA , 14 (5) 944 - 945.

Langabeer, SE; Gale, RE; Walker, H; Linch, DC; (2000) Reported cryptic rearrangements of CBFbeta-MYH11 in acute myeloid leukaemia are not due to false priming of contaminating DNA. Leukemia , 14 (5) pp. 944-945.

Law, MR; Hackshaw, AK; Wald, NJ; (2000) Mammography screening for breast cancer. Lancet , 355 pp. 749-750.

Lawrie, AS; Mackie, IJ; Purdy, G; Machin, SJ; (2000) Effect of instruments on lupus anticoagulant testing - Rebuttal. THROMB HAEMOSTASIS , 83 (2) 346 - 348.

Lea, NC; Orr, SJ; Williams, GH; Stoeber, K; Thomas, NSB; (2000) Inhibition by p16INK4A of induction and DNA-binding of the DNA replication factors Mcm2, Mcm3 and Cdc6 in human primary T-lymphocytes only occurs early during the G0/G1 transition. In: (Proceedings) American Society of Hematology 42nd Annual Meeting. (pp. 289A-289A). American Society of Hematology: Washington, US.

Ledermann, JA; (2000) High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) in ovarian cancer. INT J GYNECOL CANCER , 10 53 - 56.

Ledermann, JA; Collins, S; (2000) Clinical trials in ovarian cancer. A selection of current and recently closed randomised studies. In: Kitchener, H and Ledermann, J and Miles, A, (eds.) Key Advances in the Management of Ovarian Cancer. Aesculapius Medical Press: London.

Ledermann, JA; Herd, R; (2000) High dose chemotherapy for ovarian cancer. In: Lorigan, P and Vandenberghe, E, (eds.) An Introduction to High-Dose Chemotherapy. Harwood Academic

Leonard, P; Ledermann, J; James, R; Hochhauser, D; Seymour, M; (2000) Phase II study of irinotecan and high dose infusional 5- fluorouracil (5-FU) and folinic acid for first and second line treatment of advanced colorectal cancer. Annals of Oncology , 11 191P-.

Leonard, P; Ledermann, J; James, R; Hochhauser, D; Seymour, M; (2000) Phase II study of irinotecan and high dose infusional 5-fluorouracil (5-FU) and folinic acid for first and second line treatment of advanced colorectal cancer. ANN ONCOL , 11 44 - 45.

Leonard, P; Ledermann, JA; James, R; Hochhauser, D; Seymour, M; (2000) Phase II study of irinotecan and high dose infusional 5-FU and folinic acid (modified de Gramont) for first-line treatment of advanced or metastatic colorectal cancer. British Journal of Cancer , 83 44-.

Leonard, P; Ledermann, JA; James, R; Hochhauser, D; Seymour, M; (2000) Phase II study of irinotecan and high dose infusional 5-FU and folinic acid (modified de Gramont) for first-line treatment of advanced or metastatic colorectal cancer. BRIT J CANCER , 83 19 - 19.

Linch, DC; Gosden, RG; Tulandi, T; Tan, S-L; Hancock, SL; (2000) Hodgkin's Lymphoma: Choice of Therapy and Late Complications. Hematology Am Soc Hematol Educ Program pp. 205-221. Gold open access

Linch, DC; Smith, P; Hancock, BW; Hoskin, PJ; Cunningham, DC; Newland, AC; Milligan, D; ... Gregory, WM; + view all (2000) A randomised British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma. ANNALS OF ONCOLOGY , 11 87 - 90.

Linch, DC; Smith, P; Hancock, BW; Hoskin, PJ; Cunningham, DC; Newland, AC; Milligan, D; ... Gregory, WM; + view all (2000) A randomized British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma. Ann Oncol , 11 Sup pp. 87-90.

Lindh, M; Horal, P; Dhillon, AP; Norkrans, G; (2000) Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J VIRAL HEPATITIS , 7 (4) 258 - 267.

Lloyd, J; Flanagan, AM; (2000) Mammary and extramammary Paget's disease. J Clin Pathol , 53 (10) pp. 742-749.

Lo, SK; Tolner, B; Rogers, G; Schapira, AHV; Hartley, JA; Hochhauser, D; (2000) Assessment of mitochondrial DNA damage by chemotherapeutic agents. British Journal of Cancer , 83 56-.

Lo, SK; Tolner, B; Rogers, G; Schapira, AHV; Hartley, JA; Hochhauser, D; (2000) Assessment of mitochondrial DNA damage by chemotherapeutic agents. BRIT J CANCER , 83 22 - 22.

Lopez-Matas, M; Rodriguez-Justo, M; Morilla, R; Catovsky, D; Matutes, E; (2000) Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia. Haematologica , 85 (11) pp. 1140-1145.

Loreal, O; Gosriwatana, I; Guyader, D; Porter, J; Brissot, P; Hider, RC; (2000) Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. JOURNAL OF HEPATOLOGY , 32 (5) pp. 727-733. 10.1016/S0168-8278(00)80240-8.

Lovat, LB; Pickard, D; Novelli, M; Ripley, PM; Francis, H; Bigio, IJ; Bown, SG; (2000) A novel optical biopsy technique using elastic scattering spectroscopy for dysplasia and cancer in Barrett's oesophagus. In: (pp. TH1-).

Lovat, LB; Pickard, D; Novelli, M; Ripley, PM; Francis, H; Bigio, IJ; Bown, SG; (2000) A novel optical biopsy technique using elastic scattering spectroscopy for dysplasia and cancer in Barrett's oesophagus. In: (pp. 4919-).

Love, EM; Cohen, H; Williamson, LM; Hilary, J; (2000) Haemovigilance in the UK: What have the first three years of the serious hazards of transfusion scheme (SHOT) achieved? TRANSFUSION , 40 (10) 44S - 45S.

Love, EM; Williamson, L; Cohen, H; Jones, H; (2000) The 1998/1999 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Lowdell, MW; (2000) Autologous leukaemia-reactive cd8+ nk cells are required for long-term survival after treatment for acute leukaemia. Blood , 96 (11 PART )

Lowdell, MW; Koh, MBC; (2000) Immunotherapy of AML: future directions. J CLIN PATHOL , 53 (1) 49 - 54.

Lowdell, MW; Wood, ME; Samuel, D; Craston, R; Saha, V; Prentice, HG; (2000) Autologous leukaemia-reactive CD8+NK cells are required for long-term survival after treatment for acute leukaemia. BLOOD , 96 (11) 119A - 119A.

Lydyard, PM; Lakhani, SR; Dogan, A; Holton, JM; Patterson, KG; Bolodeoku, J; Playfair, JHL; (2000) Pathology Integrated: An A-Z of Disease and Its Pathogenesis. [Book]. Arnold: London.

M

MacLean, AB; Reid, WMN; Rolfe, KJ; Gammell, SJ; Pugh, HEJ; Gatter, KC; Fong, ACWT; ... Perrett, CW; + view all (2000) Role of angiogenesis in benign, premalignant and malignant vulvar lesions. JOURNAL OF REPRODUCTIVE MEDICINE , 45 (8) 609 - 612.

Macdonald, C; Walker, S; Watts, M; Ings, S; Linch, DC; Devereux, S; (2000) Effect of changes in expression of the amphotropic retroviral receptor PiT-2 on transduction efficiency and viral titer: Implications for gene therapy. HUM GENE THER , 11 (4) 587 - 595.

Mackay, J; (2000) Genetic testing in breast cancer patients: options for gene carriers and high risk women. In: Dixon, JM, (ed.) Breast Cancer: Diagnosis and Management. (pp. 107-112).

Mackinnon, S; (2000) Who may benefit from donor leucocyte infusions after allogeneic stem cell transplantation? BRIT J HAEMATOL , 110 (1) 12 - 17.

Madrigal, JA; Shaw, BE; Brookes, P; Potter, M; Prentice, HG; Goldman, JM; Little, AM; ... Pay, AL; + view all (2000) The genetic factors which affect the outcome of unrelated bone marrow transplantation. BLOOD , 96 (11) 1792-.

Madrigal, JA; Shaw, BE; Brookes, P; Potter, M; Prentice, HG; Goldman, JM; Little, AM; ... Pay, AL; + view all (2000) The genetic factors which affect the outcome of unrelated bone marrow transplantation. Blood , 96 (11) 1792-.

Madrigal, JA; Shaw, BE; Brookes, P; Potter, M; Prentice, HG; Goldman, JM; Little, AM; ... Pay, AL; + view all (2000) The genetic factors which affect the outcome of unrelated bone marrow transplantation. BLOOD , 96 (11) 417A - 417A.

Maini, MK; Gudgeon, N; Wedderburn, LR; Rickinson, AB; Beverley, PCL; (2000) Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype. J IMMUNOL , 165 (10) 5729 - 5737.

Mallett, SV; Peachey, TD; Sanehi, O; Hazlehurst, G; Mehta, A; (2000) Reducing red blood cell transfusion in elective surgical patients: the role of audit and practice guidelines. ANAESTHESIA , 55 (10) pp. 1013-1019. 10.1046/j.1365-2044.2000.01618-3.x.

Mangion, J; Edkins, S; Goss, AN; Stratton, MR; Flanagan, AM; (2000) Familial craniofacial fibrous dysplasia: absence of linkage to GNAS1 and the gene for cherubism. Journal of Medical Genetics , 37 (11) E37-.

Marafioti, T; Hummel, M; Foss, HD; Laumen, H; Korbjuhn, P; Anagnostopoulos, I; Lammert, H; ... Stein, H; + view all (2000) Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. BLOOD , 95 (4) pp. 1443-1450.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update April/May 2000. Hum Immunol , 61 (8) pp. 841-842.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update April/May 2000. WHO Nomenclature Committee for Factors of HLA System. Tissue Antigens , 56 (3) pp. 286-288.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update December 1999. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 55 (4) pp. 381-382.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update February 2000. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 61 (6) 630-.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update February 2000. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 55 (6) pp. 571-572.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update January 2000. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 55 (5) pp. 475-476.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update June 2000. WHO Nomenclature Committee for Factors of the HLA system. Hum Immunol , 61 (9) 950-.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update June 2000. WHO Nomenclature Committee for factor of HLA System. Tissue Antigens , 56 (3) pp. 289-290.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update March 2000. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 56 (1) pp. 103-104.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update October/November 1999. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 55 (2) pp. 191-194.

Marsh, SG; (2000) Nomenclature for factors of the HLA system, update October/November 1999. WHO Nomenclature Committee for factors of the HLA system. Hum Immunol , 61 (3) pp. 354-356.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2000) Nomenclature for factors of the HLA system, update August 2000. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 56 (6) pp. 563-564.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2000) Nomenclature for factors of the HLA system, update October 2000. Hum Immunol , 61 (12) pp. 1404-1405.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2000) Nomenclature for factors of the HLA system, update September 2000. Hum Immunol , 61 (12) 1403-.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2000) Nomenclature for factors of the HLA system, update September 2000. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 56 (6) pp. 565-566.

Marsh, SGE; (2000) Nomenclature for factors of HLA system, update August 2000. HUMAN IMMUNOLOGY , 61 (10) pp. 1055-1056. 10.1016/S0198-8859(00)00204-4.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update April/May 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (4) pp. 251-252. 10.1046/j.1365-2370.2000.00229.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update December 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (2) p. 109. 10.1046/j.1365-2370.2000.00207.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update December 1999. HUMAN IMMUNOLOGY , 61 (4) pp. 425-426. 10.1016/S0198-8859(00)00102-6.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update February 2000. TISSUE ANTIGENS , 55 (6) pp. 571-572.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update February 2000. HUMAN IMMUNOLOGY , 61 (6) p. 630. 10.1016/S0198-8859(00)00134-8.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update February 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (3) p. 161. 10.1046/j.1365-2370.2000.00219.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update January 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (3) pp. 159-160. 10.1046/j.1365-2370.2000.00210.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update January 2000. HUMAN IMMUNOLOGY , 61 (5) pp. 528-529. 10.1016/S0198-8859(00)00116-6.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update July 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (5-6) pp. 433-434.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update July 2000. HUMAN IMMUNOLOGY , 61 (10) pp. 1053-1054. 10.1016/S0198-8859(00)00205-6.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update June 2000. HUMAN IMMUNOLOGY , 61 (9) p. 950. 10.1016/S0198-8859(00)00169-5.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update June 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (5-6) p. 431.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update March 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (3) p. 163. 10.1046/j.1365-2370.2000.00224.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update October/November 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (2) pp. 105-107. 10.1046/j.1365-2370.2000.00208.x.

Marsh, SGE; (2000) Nomenclature for factors of the HLA system, update September 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 27 (1) p. 55. 10.1046/j.1365-2370.2000.00201.x.

Marsh, SGE; Parham, P; Barber, L; (2000) The HLA Factsbook. [Book]. Academic Press

Maughan, T; James, R; Kerr, D; Ledermann, J; McArdle, C; Seymour, M; Johnston, C; (2000) Excess treatment related deaths and impaired quality of life show raltitrexed is inferior to infusional 5FU regimens in the palliative chemotherapy of advanced colorectal cancer (CRC): Final results of MRC CR06. Annals of Oncology , 11 (Suppl) 185O-.

Maughan, T; James, R; Kerr, D; Ledermann, J; McArdle, C; Seymour, M; Johnston, C; (2000) Excess treatment related deaths and impaired quality of life show raltitrexed is inferior to infusional 5FU regimens in the palliative chemotherapy of advanced colorectal cancer (CRC): Final results of MRC CR06. ANNALS OF ONCOLOGY , 11 p. 43.

Mayer, A; Flynn, AA; Tsiompanou, E; Pedley, RB; Dearling, J; Boden, R; Begent, RHJ; (2000) Radioimmunotherapy is more effective in small tumours due to higher dose and dose rate. British Journal of Cancer , 83 16-.

Mayer, A; Flynn, AA; Tsiompanou, E; Pedley, RB; Dearling, J; Boden, R; Begent, RHJ; (2000) Radioimmunotherapy is more effective in small tumours due to higher dose and dose rate. In: BRIT J CANCER. (pp. 32 - 32). CHURCHILL LIVINGSTONE

Mayer, A; Shaw, J; 'Ath, SD; Price, P; Blesing, C; Corrie, P; (2000) A phase II study of gemcitabine and flutamide in advanced pancreatic cancer. BRITISH JOURNAL OF CANCER , 83 p. 18.

Mayer, A; Shaw, J; D'Ath, S; Price, P; Blesing, C; Corrie, P; (2000) Phase II study of gemcitabine and Flutamide in advanced pancreatic cancer. ANNALS OF ONCOLOGY , 11 p. 68.

Mayer, A; Tsiompanou, E; O'Malley, D; Boxer, GM; Bhatia, J; Flynn, AA; Chester, KA; ... Begent, RHJ; + view all (2000) Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody. CLIN CANCER RES , 6 (5) 1711 - 1719.

McGreavey, L; Fallen, PR; Ethel, M; Potter, M; Prentice, HG; Travers, PJ; Madrigal, JA; (2000) Analysis of reconstitution the T-cell compartment in patients undergoing stem cell transplantation. Human Immunology , 61 (Suppl) 497A-.

McGreavey, L; se, F; en, P; Ethel, M; Potter, M; Prentice, HG; nt, T; ... Madrigal, JA; + view all (2000) Analysis of reconstitution the T-cell compartment in patients undergoing stem cell transplantation. HUM IMMUNOL , 61 (Suppl) 497A-.

McHugh, PJ; Hartley, JA; (2000) Defining the pathways involved in the initiation and resolution steps of DNA interstrand crosslink repair. British Journal of Cancer , 83 139-.

McHugh, PJ; Hartley, JA; CRC Drug DNA Interactions Res Grp, ; (2000) Defining the pathways involved in the initiation and resolution steps of DNA interstrand crosslink repair. BRIT J CANCER , 83 63 - 63.

McHugh, PJ; Sones, WR; Hartley, JA; (2000) Repair of intermediate structures produced at DNA interstrand cross-links in Saccharomyces cerevisiae. MOL CELL BIOL , 20 (10) 3425 - 3433.

McMorrow, T; van den Wijngaard, A; Wollenschlaeger, A; van de Coreut, M; Monkhorst, M; Trimborn, T; Fraser, P; ... Milot, E; + view all (2000) Activation of the beta globin locus by transcription factors and chromatin modifiers. EMBO J , 19 (18) 4986 - 4996.

McNeish, IA; Kanfer, EJ; Haynes, R; Agarwal, R; Harland, SJ; Newlands, ES; Seckl, MJ; (2000) Paclitaxel-containing high dose chemotherapy for relapsed or refractory germ cell tumours. British Journal of Cancer , 83 86-.

Mehta, A; Mason, PJ; Vulliamy, TJ; (2000) Glucose-6-phosphate dehydrogenase deficiency. Best Practice and Research Clinical Haematology , 13 (1) pp. 21-38. 10.1053/beha.1999.0055.

Mehta, AB; Hoffbrand, AV; (2000) Haematology at a Glance. [Book]. Blackwell Science: Oxford.

Meja, KK; Seldon, PM; Nasuhara, Y; Ito, K; Barnes, PJ; Lindsay, MA; Giembycz, MA; (2000) p38 MAP kinase and MKK-1 co-operate in the generation of GM-CSF from LPS-stimulated human monocytes by an NF-kappa B-independent mechanism. Br J Pharmacol , 131 (6) pp. 1143-1153. 10.1038/sj.bjp.0703684.

Mestiri, S; Monastiri, K; Ben Ahmed, S; Bouaouina, N; Presneau, N; Bignon, YJ; Khairi, H; (2000) [Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women]. Arch Inst Pasteur Tunis , 77 (1-4) pp. 11-15.

Meyer, T; Rustin, GJ; (2000) Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer , 82 (9) pp. 1535-1538. 10.1054/bjoc.2000.1174.

Middleton, MR; Lee, SM; Aranc, ; A, ; Wood, M; Thatcher, N; Margison, GP; (2000) 06-methyguanine formation, repair protein depletion and clinical outcome with a 4 hr schedule of temozolomide in the treatment of advanced melanoma: results of a phase II study. International Journal of Cancer , 88 (3) pp. 469-473.

Middleton, MR; Lorigan, P; Owens, J; Ashcroft, L; Lee, SM; Harper, P; Thatcher, N; (2000) A randomised phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma. British Journal of Cancer , 82 (6) pp. 1158-1162.

Middleton, MR; Ranson, M; Lee, SM; Bridgewater, J; McElhinney, RS; McMurry, TBH; Thatcher, N; ... Margison, GP; + view all (2000) Phase I study of 4-bromothenylguanine (4-BTG, PaTrin 2), an alkyltransferase inactivator, and temozolomide. CLIN CANCER RES , 6 4574S - 4574S.

Middleton, MR; Ranson, M; Lee, SM; Bridgewater, J; McElhinney, RS; McMurry, TBH; Thatcher, N; ... Margison, GP; + view all (2000) Phase I study of 4-bromothenylguanine (4-BTG, PaTrin 2), an alkyltransferase inactivator, and temozolomide. In: (Proceedings) 11th NCI-EORTC-AACR Symposium on New Drugs in Cancer Therapy, Amsterdam.. (pp. 4574S-). Clinical Cancer Research

Millar, J; Thirlwell, C; (2000) Effects of adenosine on NMDA-responsive cells in the rat dorsal horn. JOURNAL OF PHYSIOLOGY-LONDON , 523 199P-199P.

Mills, AK; Goldstone, AH; Linch, DC; Peggs, KS; Kyriakou, C; Mackinnon, S; (2000) Long-term follow-up of allogeneic bone marrow transplants for lymphoma: The case for conventional conditioning regimens. In: BLOOD. (pp. 392A - 392A). AMER SOC HEMATOLOGY

Mitjans, F; Meyer, T; Fittschen, C; Goodman, S; Jonczyk, A; Marshall, JF; Reyes, G; (2000) In vivo therapy of malignant melanoma by means of antagonists of alphav integrins. Int J Cancer , 87 (5) pp. 716-723.

Mittnacht, S; Boshoff, C; (2000) Viral cyclins. REV MED VIROL , 10 (3) 175 - 184.

Miyakoshi, J; Mori, Y; Yaguchi, H; Ding, G; Fujimori, A; (2000) Suppression of heat-induced HSP-70 by simultaneous exposure to 50 mT magnetic field. Life Sci , 66 (13) pp. 1187-1196.

Miyakoshi, J; Yoshida, M; Yaguchi, H; Ding, GR; (2000) Exposure to extremely low frequency magnetic fields suppresses x-ray-induced transformation in mouse C3H10T1/2 cells. Biochem Biophys Res Commun , 271 (2) pp. 323-327. 10.1006/bbrc.2000.2635.

Mundee, Y; Bigelow, NC; Davis, BH; Porter, JB; (2000) Forum: journal club. Cytometry , 42 (6) pp. 394-395.

Mundee, Y; Bigelow, NC; Davis, BH; Porter, JB; (2000) Simplified flow cytometric method for fetal hemoglobin containing red blood cells. CYTOMETRY , 42 (6) 389 - 393.

Mungall, AJ; Beck, S; Cann, HM; Dunham, I; Trowsdale, J; Ziegler, A; (2000) Report of the Fourth International Chromosome 6 Workshop 1999. CYTOGENET CELL GENET , 88 (3-4) 174 - 182.

Mungall, AJ; Beck, S; Cann, HM; Dunham, I; Trowsdale, J; Ziegler, A; (2000) Report of the Fourth International Chromosome 6 Workshop 1999. 10-12 June 1999. Cambridge, UK. Abstracts. Cytogenet Cell Genet , 88 (3-4) pp. 173-196. 10.1159/000015544.

Mutimer, D; Dusheiko, G; Barrett, C; Grellier, L; Ahmed, M; Anschuetz, G; Burroughs, A; ... Elias, E; + view all (2000) Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: Long-term follow-up. TRANSPLANTATION , 70 (5) 809 - 815.

N

Nacheva, EP; Gribble, S; Andrews, K; Wienberg, J; Grace, CD; (2000) Screening for specific chromosome involvement in hematological malignancies using a set of seven chromosome painting probes - An alternative approach for chromosome analysis using standard FISH instrumentation. In: CANCER GENET CYTOGEN. (pp. 65 - 72). ELSEVIER SCIENCE INC

Napier, MP; Ledermann, JA; (2000) Novel chemotherapeutic agents in colorectal cancer. EUR J SURG ONCOL , 26 (6) 605 - 610. 10.1053/ejso.2000.0955.

Napier, MP; Ledermann, JA; (2000) Risk analysis in surgical oncology - Part I: Concepts and tools. European Journal of Surgical Oncology , 26 (6) pp. 599-604. 10.1053/ejso.2000.0954.

Napier, MP; Ledermann, JA; (2000) The management of advanced colorectal cancer. CME Bulletin Oncology , 2 (2) pp. 31-36.

Napier, MP; Sharma, SK; Springer, CJ; Bagshawe, KD; Green, AJ; Martin, J; Stribbling, SM; ... Begent, RH; + view all (2000) Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinoma. Clin Cancer Res , 6 (3) pp. 765-772.

Napier, MP; Sharma, SK; Springer, CJ; Bagshawe, KD; Green, AJ; Martin, J; Stribbling, SM; ... Begent, RHJ; + view all (2000) Antibody-directed enzyme prodrug therapy: Efficacy and mechanism of action in colorectal carcinoma. CLIN CANCER RES , 6 (3) 765 - 772.

Nathwani, AC; Hanawa, H; Vandergriff, J; Kelly, P; Vanin, EF; Nienhuis, AW; (2000) Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV. Gene Therapy , 7 (3) pp. 183-195.

Neilson, LJ; Stuart, RC; Stoeber, K; Williams, G; Going, JJ; (2000) Dysregulated expression of minichromosome maintenance proteins 2 and 5 in esophageal squamous epithelium and Barrett's mucosa. GASTROENTEROLOGY , 118 (4) A37 - A37.

Nikitenko, LL; Lloyd, BH; Rudland, PS; Fear, S; Barraclough, R; (2000) Localisation by in situ hybridisation of S100A4 (p9Ka) mRNA in primary human breast tumour specimens. INT J CANCER , 86 (2) 219 - 228.

Nikitenko, LL; MacKenzie, IZ; Rees, MCP; Bicknell, R; (2000) Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium. MOL HUM REPROD , 6 (9) 811 - 819.

Nitu-Whalley, IC; Lee, CA; Dhillon, AP; Mistry, PK; (2000) Management of liver failure in a hemophilic patient co-infected with human immunodeficiency and hepatitisC viruses. Review Series Hepatitis , 1 pp. 18-19.

Nitu-Whalley, IC; Lee, CA; Griffioen, A; Jenkins, PV; Pasi, KJ; (2000) Type 1 von Willebrand disease - a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history. BRIT J HAEMATOL , 108 (2) 259 - 264.

Noble, KE; Harkness, D; Yong, KL; (2000) Interleukin 10 regulates cellular responses in monocyte/endothelial cell co-cultures. BRIT J HAEMATOL , 108 (3) 497 - 504.

O

O'Neil, E; Wickremasinghe, RG; Jackson, T; Grant Prentice, H; Lowdell, MW; (2000) CDSαon human natural killer cells may act as a costimulatory molecule. Blood , 96 (11 PART )

O'Neil, E; Wickremasinghe, RG; Jackson, T; Prentice, HG; Lowdell, MW; (2000) CD8 alpha on human natural killer cells may act as a costimulatory molecule. In: BLOOD. (pp. 43B - 43B). AMER SOC HEMATOLOGY

Oksenhendler, E; Meignin, V; Dupin, N; Boshoff, C; Isaacson, PG; Clauvel, JP; (2000) High incidence of non-Hogkin's lymphoma (NHL) in HIV/HHV8 associated Castleman's disease (CD). JAIDS: Journal of Acquired Immune Deficiency Syndromes , 23 (3) 38-.

Oksenhendler, E; Meignin, V; Dupin, N; Boshoff, C; Isaacson, PG; Clauvel, JP; (2000) High incidence of non-Hogkin's lymphoma (NHL) in HIV/HHV8 associated Castleman's disease (CD). J ACQ IMMUN DEF SYND , 23 (3) A24 - A24.

Oliveros, JC; Blaschke, C; Herrero, J; Dopazo, J; Valencia, A; (2000) Expression profiles and biological function. In: (pp. pp. 106-117).

Orchard, KH; Cooper, MS; Wijdenes, J; Borchardt, P; Quadri, SM; Buscombe, JR; Hilson, AJ; ... Prentice, HG; + view all (2000) Pre-clinical evaluation of candidate antibodies for targeted radiotherapy for patients with multiple myeloma. Journal of Nuclear Medicine , 41 (5) 463-.

Orchard, KH; Cooper, MS; Wijdenes, J; Borchardt, P; Quadri, SM; Buscombe, JR; Hilson, AJ; ... Prentice, HG; + view all (2000) Pre-clinical evaluation of candidate antibodies for targeted radiotherapy for patients with multiple myeloma. J NUCL MED , 41 (5) 117P - 118P.

Orleans-Lindsay, JK; Prentice, HG; Lowdell, MW; (2000) Acute myleoid leukemia cells induce T cell but not NK cell unresponsiveness - Implications for the adoptive immunotherapy of leukemia. BLOOD , 96 (11) 116A - 116A.

Osborne, M; Glynne-Jones, A; Makris, A; (2000) Chemoradiation followed by immediate boost in squamous cell carcinoma of the anus. British Journal of Cancer , 83 71-.

Ouaglia, A; Prasad, N; Nozza, P; Davies, SE; Grasso, A; Burroughs, AK; Dhillon, A; (2000) Focal nodular hyperplasia-like areas in cirrhosis. J HEPATOL , 32 158 - 158.

P

Paige, AJW; Kiernan, BW; Varela, A; Rogers, MJC; Hughes, D; Steel, KP; Brown, SDM; (2000) A deletion on Chromosome 4 cosegregates with the whirler deafness mutation: exclusion of Orm1 as a candidate. MAMMALIAN GENOME , 11 (1) pp. 51-57. 10.1007/s003350010010.

Pang, KF; Ganeshaguru, K; Hart, SM; Wickremasinghe, RG; Prentice, HG; Hoffbrand, AV; Mehta, AB; (2000) Gene expression of multidrug resistant protein (MRP) homologues in B-CLL and AML cells. British Journal of Haematology , 108 71-.

Paterson, PJ; Marshall, SR; Shaw, B; Kendra, JR; Ethel, M; Kibbler, CC; Prentice, HG; (2000) Fatal invasive cerebral Absidia corymbifera infection following bone marrow transplantation. Bone Marrow Transplantation , 26 (6) pp. 701-703.

Patterson, LH; Paniwynk, Z; Pohrs, K; Teesdale-Spittle, PH; Hartley, JA; Plumb, J; (2000) A novel alkylating anthraquinone that is effective against resistant ovarian cancer cells. Proceedings of the American Association for Cancer Research , 41 2701-.

Pavlidis, N; Aamdal, S; Awada, A; Calvert, H; Fumoleau, P; Sorio, R; Punt, C; ... Hanauske, AR; + view all (2000) Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG). CANCER CHEMOTH PHARM , 46 (2) 167 - 171.

Pearson, TC; Messinezy, M; Westwood, N; Green, AR; Bench, AJ; Green, AR; Huntly, BJP; ... Finazzi, G; + view all (2000) A Polycythemia Vera Updated: Diagnosis, Pathobiology, and Treatment. Hematology Am Soc Hematol Educ Program pp. 51-68. Gold open access

Pedley, RB; Sharma, SK; Boxer, G; Flynn, AA; Boden, R; Watson, R; Dearling, J; ... Begent, RHJ; + view all (2000) Tumour eradication by combined antibody-directed and antivascular therapy. British Journal of Cancer , 83 19-.

Pedley, RB; Sharma, SK; Boxer, G; Flynn, AA; Boden, R; Watson, R; Dearling, J; ... Begent, RHJ; + view all (2000) Tumour eradication by combined antibody-directed and antivascular therapy. BRIT J CANCER , 83 13 - 13.

Pedley, RB; Sharma, SK; Boxer, GM; Flynn, AA; Boden, R; Watson, R; Dearling, J; ... R, HJ; + view all (2000) Tumour eradication by combined antibody-directed and antivascular therapy. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 13-).

Pedley, RB; Sharma, SK; Hill, SA; Boden, R; Boxer, GM; Flynn, AA; Springer, CJAB; (2000) Tumour ablation by combined antibody-directed and antivascular therapies. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 79-).

Peggs, KS; Ings, SJ; Kottaridis, PD; Yong, K; Williams, CD; Goldstone, AH; Mackinnon, S; (2000) Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: no evidence of increased incidence based on polymerase-chain-reaction monitoring. BLOOD , 96 (1) 369 - 370.

Peggs, KS; Mahendra, P; Milligan, DW; Chopra, R; Chakraverty, RK; Kottaridis, PD; Chakrabarti, S; ... UK Collaborative Grp, ; + view all (2000) Non-myeloablative transplantation using matched unrelated donors - In vivo CAMPATH-1H limits graft versus host disease. In: BLOOD. (pp. 841A - 841A). AMER SOC HEMATOLOGY

Peggs, KS; Preiser, W; Kottaridis, PD; McKeag, N; Brink, NS; Tedder, RS; Goldstone, AH; ... Mackinnon, S; + view all (2000) Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation. BRIT J HAEMATOL , 111 (3) 782 - 790.

Peggs, KS; Verfuerth, S; Khan, N; Moss, PAH; Mackinnon, S; (2000) Massive in vivo expansion of CMV-specific T-cells following adoptive transfer post allogeneic transplantation: Quantitation using HLA-peptide tetramers and T-cell receptor (TCR) spectratyping. In: BLOOD. (pp. 586A - +). AMER SOC HEMATOLOGY

Peggs, KS; Williams, CD; Chopra, R; D'Sa, S; Thuraisundaram, D; Schey, S; Craddock, C; ... UK Collaborative Study, ; + view all (2000) Non-myeloablative allogeneic transplantation with adjuvant dose escalated donor lymphocyte infusions for multiple myeloma. BLOOD , 96 (11) 781A - 781A.

Perez-Cruz, I; Fallen, P; Madrigal, JA; Cohen, SBA; (2000) Naive T cells from cord blood have the capacity to make Types 1 and 2 cytokines. IMMUNOL LETT , 75 (1) pp. 85-88.

Perez-Rodriguez, M; Corell, A; Arguello, JR; Cox, ST; McWhinnie, A; Marsh, SGE; Madrigal, JA; (2000) A new MICA allele with ten alanine residues in the exon 5 microsatellite. TISSUE ANTIGENS , 55 (2) pp. 162-165. 10.1034/j.1399-0039.2000.550209.x.

Pettet, E; Phillips, H; Jackson, S; Saunders, MI; (2000) The time span between symptom onset and the start of radiotherapy in the treatment of head and neck tumours - A retrospective review. British Journal of Cancer , 83 78-.

Pezzella, F; Munson, PJ; Miller, KD; Goldstone, AH; Gatter, KC; (2000) The diagnosis of low-grade peripheral B-cell neoplasms in bone marrow trephines. BRITISH JOURNAL OF HAEMATOLOGY , 108 (2) pp. 369-376.

Pharoah, P; Mackay, J; (2000) Medical genetics and breast cancer: current thinking on the utility of genetic screening in the determination of clinical risk. In: Mansel, R and Smith, IE and Kunkler, I and Miles, A, (eds.) The Effective Management of Breast Cancer. (pp. 13-28). Aesculapius: London.

Pickard, DCO; Lovat, L; Novelli, M; Ripley, P; Kelly, C; Bigio, IJ; Bown, SG; (2000) Diagnosis of dysplasia in Barrett's oesophagus with in-situ elastic-scattering spectroscopy. OPTICAL BIOPSY AND TISSUE OPTICS , 1 (32) 122 - 130.

Pigott, KH; Dische, S; Vojnovic, B; Saunders, MI; (2000) Sweat gland function as a measure of radiation change. Radiotherapy And Oncology , 54 (1) pp. 79-85.

Platt, GM; Cannell, E; Cuomo, ME; Singh, S; Mittnacht, S; (2000) Detection of the human herpesvirus 8-encoded cyclin protein in primary effusion lymphoma-derived cell lines. VIROLOGY , 272 (2) pp. 257-266. 10.1006/viro.2000.0343.

Porrello, A; Cerone, MA; Coen, S; Gurtner, A; Fontemaggi, G; Cimino, L; Piaggio, G; ... Soddu, S; + view all (2000) p53 regulates myogenesis by triggering the differentiation activity of pRb. J Cell Biol , 151 (6) pp. 1295-1304.

Pritchard, JK; Lewis, I; Whelan, JS; Hale, J; Pagonis, C; Durrant, LG; (2000) Immune response to the anti-idiotype cancer vaccine, 105AD7, following chemotherapy in osteosarcoma patients. In:

Q

Quaglia, AF; Blanco, GD; Greaves, R; Burroughs, AK; Dhillon, AP; (2000) Development of ductopaenic liver allograft rejection includes a "hepatitic" phase prior to duct loss. J HEPATOL , 33 (5) 773 - 780.

R

Radkov, SA; Kellam, P; Boshoff, C; (2000) The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. NAT MED , 6 (10) 1121 - 1127.

Ramon, D; Scott, I; Cox, ST; Pesoa, S; Vullo, C; Little, AM; Madrigal, JA; (2000) HLA-A*6817, identified in the Kolla Amerindians of North-West Argentina possesses a novel nucleotide substitution. Tissue Antigens , 55 (5) pp. 453-454.

Ramon, D; Scott, I; Cox, ST; Pesoa, S; Vullo, C; Little, AM; Madrigal, JA; (2000) HLA-A*6817, identified in the Kolla Amerindians of North-West Argentina possesses a novel nucleotide substitution. Tissue Antigens , 55 (5) pp. 453-454.

Raymond, EE; Fumoleau, P; Roche, H; Schellens, JHM; Dittrich, C; Punt, CJA; Droz, JP; ... Ravic, M; + view all (2000) Combined results of 4 phase I and pharmacokinetic (PK) studies of E7070, a novel chloroindolyl-sulphonamide inhibiting the activation of cdk2 and cyclin E. Clinical Cancer Research , 6 315-.

Rehman, S; Crow, J; Revell, PA; (2000) Bax protein expression in DCIS of the breast in relation to invasive ductal carcinoma and other molecular markers. Pathology and Oncology Research , 6 (4) pp. 256-263.

Rezvani, K; Lalancette, M; Szydlo, R; Mackinnon, S; Blaise, D; Slavin, S; Alessandrino, EP; ... Frassoni, F; + view all (2000) Non-myeloablative stem cell transplant (NMSCT) in AML, ALL, and MDS: Disappointing outcome for patients with advanced phase disease. BLOOD , 96 (11) 479A - 479A.

Rioja, A; Pizzey, AR; Marson, CM; Thomas, NSB; (2000) Preferential induction of apoptosis of leukaemic cells by farnesol. FEBS LETT , 467 (2-3) 291 - 295.

Robertson, JD; Gale, RE; Wynn, RF; Dougal, M; Linch, DC; Testa, NG; Chopra, R; (2000) Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns. British Journal of Haematology , 109 (2) pp. 272-279. 10.1046/j.1365-2141.2000.01970.x.

Robertson, JD; Gale, RE; Wynn, RF; Dougal, M; Linch, DC; Testa, NG; Chopra, R; (2000) Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns. BRIT J HAEMATOL , 109 (2) 272 - 279.

Robinson, J; Malik, A; Parham, P; Bodmer, JG; Marsh, SGE; (2000) IMGT/HLA Database - a sequence database for the human major histocompatibility complex. TISSUE ANTIGENS , 55 (3) pp. 280-287. 10.1034/j.1399-0039.2000.550314.x.

Robinson, J; Marsh, SG; (2000) The IMGT/HLA sequence database. Rev Immunogenet , 2 (4) pp. 518-531.

Robinson, M; Machin, S; Mackie, I; Harrison, P; (2000) In vivo biotinylation studies: specificity of labelling of reticulated platelets by thiazole orange and mepacrine. BRIT J HAEMATOL , 108 (4) 859 - 864.

Robinson, MSC; Mackie, IJ; Machin, SJ; Harrison, P; (2000) Two colour analysis of reticulated platelets. CLIN LAB HAEMATOL , 22 (4) 211 - 213.

Robinson, SP; Addada, J; Green, N; Wong, WL; Shaw, P; Chakraverty, R; Goldstone, AH; ... Linch, DC; + view all (2000) Response to short course ESHAP chemotherapy in relapsed and refractory lymphoma. BLOOD , 96 (11) 246B - 246B.

Robinson, SP; Mackinnon, S; Goldstone, AH; Slavin, S; Carella, AM; Russell, N; Taghipour, G; ... EBMT, ; + view all (2000) Higher than expected transplant-related mortality and relapse following nonmyeloablative stem cell transplantation for lymphoma adversely effects progression free survival. BLOOD , 96 (11) 554A - +.

Rogers, S; Whelan, JS; (2000) Cerebral metastases from malignant fibrous histiocytoma of bone. Sarcoma , 4 pp. 125-128. Gold open access

Rolfe, KJ; Crow, JC; Benjamin, E; Reid, WMN; MacLean, AB; Perrett, CW; (2000) Abnormalities in the G1/S cell cycle checkpoint in vulval cancer. BRIT J OBSTET GYNAEC , 107 (6) 817 - 817.

Roos, DE; Davis, SR; O'Brien, PC; Hoskin, PJ; (2000) Eligibility audits form the randomised neuropathic bone trial (TROG 96.05). Australasian Radiology , 44 pp. 303-307.

Roos, DE; O'Brien, PC; Smith, JG; Spry, NA; Hoskin, PJ; Burmeister, BH; Turner, SL; (2000) A role for radiotherapy in neuropathic bone pain: Preliminary response rates from a prospective trial (Trans-Tasman Radiation Oncology Group, TROG 96.05). International Journal of Radiation Oncology Biology Physics , 46 (4) pp. 975-981.

Rubin, E; Mittnacht, S; Ludlow, JW; (2000) Mechanism of pRb activation following mitosis. FASEB JOURNAL , 14 (8) A1544-A1544.

Rudd, RM; Gower, NH; James, LE; Gregory, W; Eisen, TQ; Lee, SM; et, A; (2000) A phase II/III randomised comparison of gemcitabine/carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIC) in advanced non-small cell lung cancer (NSCLC). In: (Proceedings) 9th World Conference on Lung Cancer, Tokyo, Japan.. (pp. 21-). Lung Cancer

Rudd, RM; James, LE; Gower, NH; Gregory, W; Eisen, TQ; Harper, PG; Gilligan, D; ... Spiro, SG; + view all (2000) A phase II/III randomised comparison of gemcitabine/carboplatin (GC) with cisplatin/etoposide (PE) in patients with poor prognosis small cell lung cancer (SCLC). Lung Cancer , 29 (S1) 47-.

Ruiz, M; Giudicelli, V; Ginestoux, C; Stoehr, P; Robinson, J; Bodmer, J; Marsh, SGE; ... Lefranc, MP; + view all (2000) IMGT, the international ImMunoGeneTics database. Nucleic Acids Research , 28 (1) pp. 219-221. Gold open access

S

Sabin, CA; Yee, TT; Devereux, H; Griffioen, A; Loveday, C; Phillips, AN; Lee, CA; (2000) Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapy. AIDS , 14 (8) 1001 - 1007.

Sabin, CA; Yee, TT; Devereux, H; Griffioen, A; Loveday, C; Phillips, AN; Lee, CA; (2000) Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapy. AIDS , 14 (8) pp. 1001-1007.

Saifuddin, A; Whelan, J; Pringle, JAS; Cannon, SR; (2000) Malignant round cell tumours of bone: atypical clinical and imaging features. SKELETAL RADIOL , 29 (11) 646 - 651.

Salomoni, P; Condorelli, F; Sweeney, SM; Calabretta, B; (2000) Versatility of BCR/ABL-expressing leukemic cells in circumventing proapoptotic BAD effects. BLOOD , 96 (2) 676 - 684.

Salomoni, P; Pandolfi, PP; (2000) Role of Daxx in B cell selection and apoptosis by CD40. BLOOD , 96 (11) 569A - +.

Salomoni, P; Pandolfi, PP; (2000) Transcriptional regulation of cellular transformation. NAT MED , 6 (7) 742 - 744.

Salto-Tellez, M; Kocjan, G; (2000) Lymphocytic mastopathy in a patient with previous breast cancer diagnosed by fine-needle aspirate. DIAGN CYTOPATHOL , 23 (2) 141 - 142.

Salto-Tellez, M; Saunders, C; Kocjan, G; (2000) Diagnosis of multiple granular cell tumours by fine needle aspiration cytology. CYTOPATHOLOGY , 11 (3) 191 - 193.

Saunders, MI; (2000) The implications and opportunities of the CHART trial in the treatment of non-small cell lung cancer. British Journal of Cancer , 83 S5-.

Savage, K; Waller, HA; Khan, K; Dhillon, AP; Grimes, S; Michaeli, D; Pounder, RE; ... Caplin, ME; + view all (2000) Expression of CCK-B/gastrin receptor and endocytosis of anti-CCK-B/gastrin receptor antibody. Gut , 46 (S2) W96-.

Savage, K; Waller, HA; Khan, K; Dhillon, AP; Grimes, S; Michaeli, D; Pounder, RE; ... Caplin, ME; + view all (2000) Expression of CCK-B/gastrin receptor and endocytosis of anti-CCK-B/gastrin receptor antibody. Gastroenterology , 118 (4) 616-.

Savage, K; Waller, HA; Khan, K; Dhillon, AP; Grimes, S; Michaeli, D; Pounder, RE; ... Caplin, ME; + view all (2000) Expression of CCK-B/gastrin receptor and endocytosis of anti-CCK-B/gastrin receptor antibody. GUT , 46 A56 - A56.

Savage, K; Waller, HA; Khan, K; Dhillon, AP; Grimes, S; Michaeli, D; Pounder, RE; ... Caplin, ME; + view all (2000) Expression of CCK-B/gastrin receptor and endocytosis of anti-CCK-B/gastrin receptor antibody. GASTROENTEROLOGY , 118 (4) A86 - A86.

Sebire, NJ; Lader, CS; Roberts, L; Flanagan, AM; (2000) First trimester maternal serum Macrophage Colony-Stimulating Factor (M-CSF) is raised in pregnancies with subsequent severe pre-eclampsia. In: J PATHOL. (pp. 30A - 30A). JOHN WILEY & SONS LTD

Seitz, V; Hummel, M; Marafioti, T; Anagnostopoulos, I; Assaf, C; Stein, H; (2000) Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. BLOOD , 95 (10) pp. 3020-3024.

Shah, EF; Woodside, J; Chatterjee, R; Stein, R; Saunders, C; (2000) The role of Zoladex in the prevention of ovarian damage during chemotherapy for primary breast cancer. BRIT J CANCER , 83 40 - 40.